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Oxidative stress, intense light exposure and oxygen imbalances such as hypoxic or 
hyperoxic conditions perturb mitochondria, nuclear function and further lead to cellular 
damage of retina and retinal pigment epithelial (RPE) cells. Our major aim is to 
understand the various biochemical and proteomic events that occur during the 
progression of retina and RPE cell death. The comprehensive objectives of this 
dissertation are to understand the functional aspects of protein expression, 
posttranslational modifications, protein or lipid binding changes, phenotypic, 
morphological alterations and their regulation during the retina and RPE apoptosis under 
oxidative stress. The entire study is divided into four chapters Chapter 1 contains 
introduction and background on apoptotic signaling in retina and RPE cells. In chapter 2, 
we demonstrated that the oxidative stress biomarker prohibitin shuttles between 
mitochondria and nucleus as an anti-apoptotic molecule and acts as a transcriptional 
regulator by altering its lipid binding affinity and by posttranslational modifications 
during oxidative damage to the retina and RPE. In chapter 3, we demonstrated that 
oxidative and photo-oxidative stress induced nitric oxide regulates the RPE apoptosis by 
altering serine/threonine protein phosphatase 2A (PP2A) catalytic subunit, vimentin 
phosphorylation and Bcl xL expression regulation in the RPE cells in vitro. In chapter 4, 
we further analyzed the differential expression of prohibitin in the retina and RPE during 
oxidative stress, diabetic retinopathy (DR) and age-related macular degeneration (AMD) 
condition. Our analysis of postmortem retinas reveals that prohibitin is significantly 
increased in aged and AMD retina, and decreased in retinas of human diabetic 
retinopathy and RPE of AMD. Our study demonstrates that prohibitin levels determine 







CHAPTER 1: INTRODUCTION AND BACKGROUND 
Eye is a complex organ of the human body which contains different parts with various 
functions indispensable for clear vision. The front portion of the eye with transparent 
dome shaped structure which covers the iris and pupil is called cornea. Cornea helps in 
protecting the inner parts of the eye and focuses the light that enters the eye. Lens is 
another transparent oval shaped body compacted with crystalline, which directs the 
movement of light towards the retina to initiate the visual transduction. The vitreous 
humor is clear and colorless substance within the anterior chamber that fills the space 
between lens and retina. Retina is the neural portion of the eye which comprises of 
different classes of neurons such as photoreceptors (rods and cones), bipolar cells, 
ganglion cells, horizontal cells and amacrine cells. Retina is connected to the central 
nervous system. Retinal pigment epithelium (RPE) is the single layer of cells located 
underneath the neurosensory retina firmly attaching to the choroid. 
1.1. Role of oxidative stress in the retina and RPE during the progression of retinal 
degenerative diseases 
Retinal pigment epithelium (RPE) is highly pigmented, hexagonally packed cuboidal 
monolayered epithelium located on the Bruch’s membrane between the neural retina and 
the choriocapillaries. RPE performs various functions such as phagocytosis of 
photoreceptor outer segments, transportation of nutrients, protection against reactive 
oxygen species, synthesis of vitamin-A metabolites (retinoid recycling) and  maintaining 
the retina blood barrier which are highly indispensable for sustaining vision (Zangwill et 
al., 2000).  High metabolic activities and visual signal transduction process in the retina, 
especially in macula contributes high oxygen tension in RPE (Alder and Cringle, 1985).  
Although  the retina and RPE  have powerful oxygen regulating mechanism, formation of 
reactive oxygen species (ROS) are predictable during  pathophysiological conditions of 
Age-related macular degeneration (AMD), retinitis pigmentosa (RP), diabetic retinopathy 
(DR) and retinopathy of prematurity (ROP). Intense light exposure has been linked to the 
ocular damage which may cause the development of AMD, possibly due to the oxidative 
damage to the RPE layer (Taylor et al., 1992). Frequency of retinal irradiation, presence 
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of chromophores/photo sensitizers, oxidation of poly unsaturated fatty acids (PUFA) such 
as Docohexanoic acids (DHA)  in RPE  provide an ideal environment for the generation 
of ROS (Beatty et al., 2000). Lack of protective mechanism against the oxidative damage 
may initiate the choroidal neovascularization in mouse model (Dong et al., 2009). 
Although the accumulation of photo-toxic ROS, lipo-protein complexes (drusen) suggests 
a correlation between oxidative stress and AMD, the mechanism of RPE apoptosis under 
oxidative stress is elusive. We speculated that identification of oxidative stress induced 
biomarkers in the retina and RPE provides novel insights towards signaling mechanism 
of retinal degeneration at the molecular level. Since oxidative stress contributes the 
progressive cell death of retina and RPE, our previous research team performed the 
proteomic analysis from bovine and human RPE cells under oxidative stress environment 
(Arnouk et al., 2011a). They found that aging related mitochondrial protein prohibitin is 
down-regulated in the bovine RPE cells along with the differential expression of several 
other proteins such as apoptotic related, DNA repair, respiratory chain related proteins 
(COX). Our later studies focused on the multifunctional protein prohibitin in the retina 
and RPE under elevated oxidative stress. Our proteomic approaches revealed that 
prohibitin is down regulated in the RPE, where as it was upregulated in the retina from 
aged and diabetic rat model. Our further proteomic studies confirm the tissue specific and 
sub cellular localization (mitochondria and nucleus) of prohibitin in the retina (ganglion 
cell, outer and inner nuclear layer) and RPE. (Lee et al., 2010a). Subsequently, we are 
interested in the functional role of prohibitin and its regulation in the RPE under 
oxidative.  Our proteomic analysis provides the evidence that prohibitin communicates 
between the mitochondria and nucleus, acts as an anti-apoptotic molecule and 
transcription regulator in the retina and RPE under oxidative stress (Sripathi et al., 
2011a).  
1.2 Multifunctional role of prohibitin (PHB) in the retina and retinal pigment 
epithelium (RPE) under oxidative stress 
Prohibitin is a highly conserved mitochondrial membrane protein with the molecular 
mass of` 30-32 kDa, located on chromosome 17 at q21. The amino acid sequence of 
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prohibitin in rat and mouse are identical and differ from the human prohibitin sequence 
by single amino acid (Mcclung et al., 1995b). The prohibitin complex (PHB1, PHB2) 
have been identified in mitochondria and plasma membrane as they both bind together 
to form a heterodimer and  anchor to inner mitochondrial membrane through N 
terminalhydrophobic regions present in PHB1 and PHB2 (Artal-Sanz and Tavernarakis, 
2010). Prohibitin acts as a potential tumor suppressor with anti-proliferative activity by 
regulating the cell cycle progression and apoptosis (Nuell et al., 1991). PHB1 co 
localizes in the nucleus with E2F1, retinoblastoma protein pRb2 and p53 to modulate 
transcriptional activity and recruit HDAC1 towards the repression of histone 
deacetylation (Wang et al., 2002a). Differential expression, regulation of both 
mitochondrial and nuclear genes may alter the sub cellular translocalization and 
function of a protein. Nuclear genes enable the mitochondrial- nuclear shuttling as seen 
in case of breast cancer cell lines (Delsite et al., 2002). 
 Irrespective of various cancers, neurodegenerative diseases, functional aspects of 
prohibitin in the eye are not well studied yet. The multifunctional protein prohibitin is 
significantly down regulated in bovine and human  RPE cells under oxidative stress 
(Arnouk et al., 2011a). Our proteomic studies reveal that prohibitin is involved in the 
oxidative stress induced cell signaling and is identified as an oxidative stress biomarker 
in the retina and RPE. Prohibitin expression is controlled by oxidative, light induced 
stress and shows the differential expression levels in aged and diabetic retina (Lee et al., 
2010a). We found that prohibitin translocalizes between mitochondria and nucleus by 
binding with the membrane lipid cardiolipin, tumor suppressor protein p53 and by the 
differential phosphorylation. Prohibitin knockdown approach using small interfering 
RNA (siRNA) demonstrate the elevated apoptotic signaling in the RPE under oxidative 
stress and prohibitin is considered as an anti-apoptotic protein in the RPE (Sripathi et 
al., 2011b). We also observed that the prohibitin expression was down regulated in the 
diabetic retinopathy of rat, mouse and human RPE. On the other hand, prohibitin 
expression was significantly upregulated in the aged retinas from rat, mouse and human. 
Interestingly, our western blotting analysis showed that prohibitin levels increased in 
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both central (macula) and peripheral retinal regions, whereas the levels in the central 
(macula)  and peripheral regions of  RPE were  significantly decreased from the age-
related macular degeneration (AMD) donor eyes compared to the age matched controls. 
To investigate the various functional properties of prohibitin and its relevant signaling 
pathways, we aimed to understand the prohibitin’s potential binding partners and its 
interacting network using different proteomic approaches such as co-
immunoprecipitation and MALDI-TOF mass spectrometry.   
1.3 Nitric oxide (NO) regulated cytoskeleton reorganization and apoptosis in the 
RPE under oxidative stress 
Nitric oxide is a soluble atmospheric gas synthesized in different cell types and freely 
diffusible across the cell membrane.  Nitric oxide synthases (NOS) generates the nitric 
oxide by the oxidation of guanidino nitrogen of its substrate L-arginine. The reaction 
occurs in the presence of oxygen and NADPH with the formation of citrulline and 
NADP as byproducts. Three different isoforms of NOS have been identified from 
different genes with different localization, catalytic action, regulation and inhibition 
(Marletta et al., 1988; Nathan, 1992). Nitric oxide is synthesized by three different 
isoforms of nitric oxide syntheses (NOS) such as NOS-I (nNOS), NOS-II (iNOS) and 
NOS-III (eNOS). nNOS is the first and predominating isoform mainly localized in the 
neuronal tissue of central and peripheral nervous system, amacrine cells, bipolar cells 
and photoreceptor (rod and cone) cells (Koch et al., 1994; Perez et al., 1995; Yamamoto 
et al., 1993). Inducible nitric oxide synthase (iNOS) is a calcium dependent inducible 
isoform generated by the immunological or inflammatory stimuli and the expression is 
observed in the retinal Müller glial and retinal pigment epithelial cells after stimulation 
with cytokines (IFN γ) and endotoxins (LPS) (Goureau et al., 1994). Recently, iNOS 
expression was also identified in the retinal pericytes and capillary endothelial cells 
(Chakravarthy et al., 1995). The calcium dependent eNOS isoform expresses in the 
vascular endothelial cells and generates lower levels of nitric oxide. Endothelial nitric 
oxide synthase (eNOS) expression was identified in endothelial cells of the blood 
vessels located on the vitreous surface, between the nerve fiber layer (NFL), axons of 
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retinal ganglion cell layer (GCL), choroid and vascular endothelium of anterior segment 
(Osborne et al., 1993). Various studies confirmed that nitric oxide acts as a neuro 
modulator of synaptic transmission due to the modifications of electrical coupling in the 
retinal horizontal cells (Miyachi et al., 1990). Nitric oxide generated from endothelial 
and neuronal cells plays a major role in the regulation of cerebral blood flow (Estrada 
and DeFelipe, 1998), synaptic transmission (Holscher, 1997). Rat RPE cells generates 
higher levels of nitric oxide via inducible nitric oxide synthase (iNOS) in response to 
endotoxin lipopolysaccharide (LPS), cytokines interferon-γ (IFN- γ),tumor necrosis 
factor- α (TNF-α) and competitively inhibited with the treatment of nitric oxide 
synthase inhibitor NG-Monomethyl-L-Arginine (L-NMMA) and cycloheximide 
(Liversidge et al., 1994). Our studies reveal that RPE generates nitric oxide in 
concentration and time dependent manner under light, oxidative stress and re-
oxygenation conditions. However, the physiological levels of nitric oxide produced in 














CHAPTER 2: MITOCHONDRIAL−NUCLEAR COMMUNICATION BY 
PROHIBITIN SHUTTLING UNDER OXIDATIVE STRESS1 
Srinivas R. Sripathi, Weilue He, Cameron L. Atkinson, Joseph J. Smith, Zhicong Liu, 














                                                             
1 The material included in this chapter was previously published in the journal  
Biochemistry, 2011, 50 (39), pp 8342–8351DOI: 10.1021/bi2008933 
Publication Date (Web): August 31, 2011Copyright © 2011 American Chemical Society 
http://pubs.acs.org/doi/abs/10.1021/bi2008933 
This study was supported by the Century II Equipment fund and the Research Excellence 







        Mitochondrial-nuclear communication is critical for maintaining mitochondrial 
activity under stress conditions. Adaptation of the mitochondrial-nuclear network to 
changes in the intracellular oxidation and reduction milieu is critical for the survival of 
retinal and retinal pigment epithelial (RPE) cells, in relation to their high oxygen demand 
and rapid metabolism. However, the generation and transmission of the mitochondrial 
signal to the nucleus remain elusive. Previously, our in vivo study revealed that prohibitin 
is up regulated in the retina, but down regulated in RPE cells in the aging and diabetic 
model. In this study, the functional role of prohibitin in the retina and RPE cells was 
examined using biochemical methods, including a lipid binding assay, two-dimensional 
gel electrophoresis, immunocytochemistry, Western blotting, and a knockdown approach. 
Protein depletion by siRNA characterized prohibitin as an anti-apoptotic molecule in 
mitochondria, while the lipid binding assay demonstrated sub cellular communication 
between mitochondria and the nucleus under oxidative stress. The changes in the 
expression and localization of mitochondrial prohibitin triggered by reactive oxygen 
species are crucial for mitochondrial integrity. We propose that prohibitin shuttles 
between mitochondria and the nucleus as an anti-apoptotic molecule and a transcriptional 















Mitochondrial-nuclear reciprocal signaling is the central question that needs to be 
answered to understand the maintenance mechanism of appropriate mitochondrial 
activities and functions in neurodegeneration. Disruptions of the mitochondrial-nuclear 
network lead to accelerated aging and age-related diseases. Considering the significant 
consequences of mitochondrial dysfunction in neurodegeneration and aging, it is crucial 
to understand the molecular mechanisms of mitochondrial−nuclear communication by 
protein shuttling (Cannino et al., 2007; Ryan and Hoogenraad, 2007). Cellular proteome 
changes, including expression, localization, and modifications, to adapt an oxidative 
environment are critical for the survival of retinal and retinal pigment epithelial (RPE) 
cells, because of their high oxygen demand and upregulated metabolism, especially under 
constant phototransduction. Oxidative stressors, including reactive oxygen species (ROS) 
and a hypoxic environment, are serious risk factors in retinal degeneration, including age-
related macular degeneration (AMD) and diabetic retinopathy (DR). Understanding the 
molecular mechanisms that mediate oxidative stress-induced proteome changes and 
protein translocalization between mitochondria and nuclei may provide insight into 
pathogenesis of retinal degeneration. Previously, our proteomic study demonstrated that 
prohibitin is involved in oxidative stress signaling in the retina and RPE cells (Arnouk et 
al., 2011b; Lee et al., 2010a). An in vivo study revealed that the aging process 
upregulated prohibitin in the retina and decreased its level in RPE cells. Prohibitin was 
first reported as an anti-proliferative protein or a tumor suppressor that binds to p53, E2F, 
and Rb (McClung et al., 1989; Nijtmans et al., 2000a). It forms a high-molecular mass 
complex with its isoform, prohibitin 2, in mitochondria (Steglich et al., 1999). 
Localization of prohibitin has been controversial, possibly because of cell type and 
extracellular stress, in being identified as mitochondrial, nuclear, or cell surface (Rivera-
Milla et al., 2006; Wang et al., 2002b). Prohibitin is ubiquitous in organisms ranging 
from bacteria to plants to humans, but its function is not clearly understood at the 
molecular level in each sub cellular organelle (McClung et al., 1995a). Prohibitin is 
proposed to have roles as a cell cycle inhibitor, transcriptional regulator, inflammatory 
modulator, plasma membrane receptor, and mitochondrial chaperone (Kolonin et al., 
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2004a; Mishra et al., 2005; Nijtmans et al., 2000a; Patel et al., 2010; Sharma and Qadri, 
2004a; Theiss et al., 2007b; Wang et al., 1999a; Wang et al., 1999b). Prohibitin plays a 
role in apoptosis and aging by stabilizing newly synthesized respiratory enzymes; 
however, its presence and function in the eye have never been elucidated (Bourges et al., 
2004; Nijtmans et al., 2002). In this study, we examined the antiapoptotic function and 
the altered lipid interactions of prohibitin under oxidative stress. Translocalization of 
prohibitin was observed between mitochondria and the nucleus as apoptotic signaling. 
The changes in the expression and location of mitochondrial prohibitin triggered by redox 
imbalance mediated by ROS suggest a critical role of prohibitin translocalization in the 
maintenance of mitochondrial integrity. Here, we demonstrate that prohibitin is a new 
dynamic regulator of mitochondrial and nuclear functions under stress in the retina and 
RPE cells. Knockdown of prohibitin upregulated pro-apoptotic factors, including BAK 
and caspases, and decreased the levels of anti-apoptotic molecules such as BCL-xL. The 
significance of our study resides in our characterization of prohibitin as a mitochondrion-
nucleus shuttle to respond to ROS as an anti-apoptotic protein and also as a 
transcriptional regulator by binding to p53 in the nucleus. 
2.3 Materials and methods  
2.3.1 ARPE-19 Cell Culture 
ARPE-19 cells were transferred to tissue culture flasks (Nunc, Roskilde, Denmark) 
containing Dulbecco’s modified Eagle's medium (DMEM) supplemented with 10% fetal 
bovine serum (FBS) and 1% penicillin/ streptomycin and the flasks placed in a 5% CO2 
incubator at 37 °C. After proliferation, cells were retrypsinized with a 0.1% trypsin-
EDTA solution (Sigma, St. Louis, MO) for 5 min at 37 °C. After centrifugation (125g for 
7 min), cells were plated in 24- or 6-well plates (Nunc) at a density of 2 × 104 or 8 × 104 
cells/well, respectively, and allowed to grow to confluence for 2−4 days. Eight- to 
twelve-passage cells were used for experiments (Davis et al., 1995; Dunn et al., 1996). 
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2.3.2 Oxidative Stress Treatment 
ARPE-19 cells were incubated with fresh medium for 12 h before being treated. 
Hydrogen peroxide (Mallinckrodt Inc.) was diluted (50, 100, 200, and 250 μM) in FBS-
free medium. Cells were washed with PBS three times before being treated. Cells were 
treated with H2O2 for 1, 2, 4, 6, 8, 12, and 24 h at 37 °C in a 5% CO2 incubator. Medium 
was removed immediately after the treatment, and cells were washed with PBS and 
harvested. Cells were lysed by RIPA buffer [0.5 M Tris-HCl (pH 7.4), 1.5 M NaCl, 2.5% 
deoxycholic acid, 10% NP-40, and 10 mM EDTA (Millipore)] containing protease 
inhibitor cocktail (Thermo Scientific) for sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS−PAGE) and Western blot analysis or immunocytochemistry. 
Immunocytochemistry. ARPE-19 cells were incubated with the final concentration of 100 
nM MitoTracker Orange CMTMRos (Molecular Probes, Carlsbad, CA) in FBS-free 
culture medium for 30 min at 37 °C. After being washed in PBS, cells were fixed with 
10% formaldehyde in PBS for 25 min at room temperature, and the membrane was 
permeabilized with 0.2% Triton X-100 (Sigma) in PBS for 20 min. Cells were blocked 
with complete medium containing 10% FBS and 0.05% Tween 20 (Sigma) for 1 h. Cells 
were incubated with the anti-prohibitin antibody (1:500; Genemed Synthesis Inc., San 
Antonio, TX) overnight at 4 °C. After being washed with PBS three times, cells were 
incubated with Alexa Fluor 488- conjugated anti-rabbit IgG (1:700; Molecular Probes) 
for 1 h at 25 °C. Finally, cells were mounted with VECTASHIELD Mounting Medium 
with DAPI (4, 6-diamidino-2- phenylindole) to counterstain the nucleus. Images were 
acquired using a Zeiss AxioVert 200 M Apo Tome fluorescent microscope with 63× 
magnification.  
2.3.3 Co-Immunoprecipitation 
ARPE-19 cells were homogenized in lysis buffer [25 mM Tris, 120 mM NaCl, 0.3% 
Triton X- 100, 15% glycerol, 2 mM PMSF, 10 mM EDTA, 0.2% sodium orthovanadate, 
and protease inhibitor cocktail]. Cells were lysed by repeated freeze−thaw cycles and 
sonication (3 × 5 min), followed by centrifugation at 13000g for 30 min. Proteins in 
supernatant were purified by using control agarose resin, cross-linked by 4% bead 
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agarose, to minimize nonspecific binding. The purified anti-prohibitin antibody was 
immobilized with amino-linked protein A beads in the column with coupling buffer [0.5 
mM sodium phosphate and 7.5 mM NaCl (pH 7.2)] and incubated with 3 μL of 5 M 
sodium cyanoborohydride on a shaker at 25 °C for 2 h. Columns were washed with a 
washing buffer [0.025 M Tris, 0.15 M NaCl, 0.001 M EDTA, 1% NP-40, and 5% 
glycerol (pH 7.4)]. Protein samples were incubated in the protein A−antibody column 
with gentle mixing overnight at 4 °C. Columns were washed three times to remove 
nonspecific binding proteins. Samples were equilibrated with Laemmli sample buffer 
containing 100 mM DTT. Eluted proteins were separated by SDS−PAGE and visualized 
by Western blot analysis using primary antibodies against prohibitin and p53. Protein 
bands on the gel were visualized by silver staining (Bio-Rad, Hercules, CA). 
2.3.4 Two-Dimensional SDS−PAGE 
  Protein samples were purified with the ReadyPrep 2-D Cleanup Kit (Bio-Rad) and 
quantified using the BCA protein assay kit (Pierce, Rockford, IL). One hundred fifty 
micrograms of protein was incubated in 200 μL of rehydration buffer (8 M urea, 2 M 
thiourea, 2% CHAPS, and 50 mM DTT) and supplemented with 0.5% destreak IPG 
buffer (pH 3−10) (GE Healthcare). Isoelectric focusing was conducted using 11 cm 
immobiline dry strips (Bio-Rad) with linear pH 3 to 10 and pH 4 to 7 gradients. Strips 
were rehydrated for 12 h at 20 °C. Proteins were separated with the Ettan IPGphor-3 
instrument (GE Healthcare) using programmed voltage gradients at 20 °C for a total of 
12 kVh (1 h at 500 V, 1 h at 1000 V, 2 h at 6000 V, and 40 min at 6000 V). The IPG 
strips were reduced in equilibration buffer I [0.375 M Tris-HCl (pH 8.8), 6 M urea, 20% 
glycerol, 2% SDS, and 50 mM DTT] for 20 min at 25 °C and alkylated for 20 min in 
equilibration buffer II containing 150 mM iodoacetamide. The equilibrated strips were 
placed on top of polyacrylamide gels (8−16%; Bio-Rad) and sealed with 1% agarose 
buffer. Proteins were visualized by Coomassie staining using Imperial Protein Stain 
(Pierce) and Western blot analysis.  
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2.3.5 In-Gel Digestion and Mass Spectrometry 
 Selected protein spots from two-dimensional (2D) electrophoresis were excised from 
gels. The gel pieces were destained twice with 200 μL of 50% acetonitrile (MeCN)/25 
mM NH4HCO3 buffer (pH 8.0) at room temperature for 20 min, washed once with 200 
μL of 100% MeCN, and vacuum-dried with a Speed Vac concentrator (Savant, Holbrook, 
NY). The gel pieces were rehydrated with 13 ng/μL sequencing grade modified trypsin 
(Promega, Madison, WI) in 25 mM NH4HCO3 and incubated at 37 °C overnight. 
Peptides were subsequently extracted twice with 50 μL of a 50% MeCN/5% formic acid 
mixture for 15 min at 37 °C. All extracts were combined and dried. The peptide extracts 
were purified using the C18 ZipTip (Millipore). The peptides were eluted with 5 μL of a 
75% MeCN/0.1% TFA mixture. The samples were analyzed by MALDI-TOF or tandem 
ESI MS/MS as previously described (Arnouk et al., 2011b; Lee et al., 2010a; Lee et al., 
2010b; Lee et al., 2011; Zhang et al., 2010a). 
2.3.6 Subcellular Fractionation  
       Bovine retinal tissues were separated and proteins isolated by the Cox and Emili 
method, which uses different centrifugation in density gradients to generate nuclear, 
mitochondrial and cytosolic protein components (Cox and Emili, 2006b). Cold PBS-pre 
rinsed tissue was homogenized in homogenization buffer and centrifuged at 800g for 15 
min. The pellet was resuspended for further isolation of nuclear proteins. The supernatant 
was collected and centrifuged at 6000g for 15 min. The pellet was saved for mitochondria 
and supernatant for cytosol-microsome separation. The crude nuclear fraction was 
suspended in nuclear extraction buffer and separated by ultracentrifugation at 80000g for 
35 min. To obtain mitochondrial membrane and matrix protein, the pellet was 
resuspended in membrane extraction hypotonic lysis buffer centrifuged at 9000g for 30 
min. Cytosolic proteins were obtained by spinning the supernatant for 1 h at 10,0000g. 
2.3.7 SDS−PAGE and Western Blot Analysis 
        Protein quantification was conducted with the BCA protein assay kit (Pierce). 
Samples were dissolved in Laemmli sample buffer [62.5 mM Tris-HCl (pH 6.8), 25% 
glycerol, 2% SDS, and 0.01% bromophenol blue]. Proteins were resolved using 8 to 16% 
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polyacrylamide precast gels (Bio-Rad), followed by electrotransfer onto the methanol-
activated PVDF membrane, and blocked in 5% nonfat milk prepared in TTBS [0.1% 
(v/v) Tween 20] for 1 h at 25 °C. The membranes were incubated with primary antibodies 
at 4 °C overnight and subsequently incubated with corresponding horseradish peroxidase-
conjugated secondary antibodies for 1 h at 25 °C. Proteins were visualized by using West 
Pico Chemiluminescent Substrate (Pierce). Immunoreactive protein bands were acquired 
using a LAS 4000 mini luminescent image analyzer and quantified using Quantity One 
(Bio-Rad). Proteins in gels were stained with Imperial Protein stain and scanned using a 
GS800 imaging densitometer (Bio-Rad). 
2.3.8 Lipid−Protein Interaction Assay 
         Lipid strips were purchased from Echelon Biosciences or prepared using a 
nitrocellulose membrane in the lab. For commercially available lipid strips, membranes 
with a solvent blank control and 15 different lipids were initially blocked with 
SuperBlock (Pierce) blocking buffer for 1 h at room temperature. To prepare our own 
lipid strips, we spotted different amounts of lipids (100 pmol to 10 nmol), including 
cardiolipin, cholesterol, and phosphatidylserine, onto the nitrocellulose membrane. The 
membrane was air-dried for 1 h at room temperature. Crude proteins, fractionated 
samples, or prohibitin partially purified by co-IP (1 μg/mL) from control ARPE-19 cells 
or cells under oxidative stress (200 μM H2O2) was incubated with a nitrocellulose 
membrane overnight. The membrane was washed three times with TTBS buffer [Tris-
buffered saline with 0.1% (v/v) Tween 20], followed by incubation with the prohibitin 
antibody (1:1000; Genemed Synthesis Inc.) overnight at 4 °C with gentle agitation. Blots 
were washed with TTBS buffer and incubated with horseradishperoxidase conjugated 
anti-rabbit secondary antibody (1:10000; Agrisera, Sweden) for 1 h at 25 °C. Strips were 
developed with Super Signal West Pico Chemiluminescence Substrate (Pierce), and 
proteins were visualized using a LAS 4000 mini luminescent image analyzer (Fuji). 
2.3.9 siRNA Transfection 
ARPE-19 cells were seeded in 24-well plates at a density of 6 × 104 cells/well with 0.1 
mL of DMEM containing 10% FBS and 1% penicillin/streptomycin. Cells were 
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incubated at 37 °C with 5% CO2. Cells were treated with 175 ng (final concentration of 
23 nM) of siRNA (AAAGCCAGCTTCCTCGCATCT) against prohibitin (FlexiTube 
siRNA) and random sequence control siRNA in 100 μL of culture medium without 
serum. Transfection was conducted with HiPerFect transfection reagent (Qiagen, 
Valencia, CA), and cells were harvested 48 h post-transfection. Proteins were assayed by 
Western blot for detection of AIF (EMD Millipore), BCL-xL (sc-634; Santa Cruz 
Biotechnology), caspase-9 (AB16969; EMD Millipore), BAK (ab32371; Abcam), and 
actin (sc-47778; Santa Cruz Biotechnology). Protein localization and expression were 
also analyzed by immunocytochemistry. 
2.4 Results  
2.4.1 Mitochondrial−Nuclear Trafficking of Prohibitin  
Oxidative stress induced by hydrogen peroxide has been implicated in many ocular 
diseases. RPE cells maintain a reducing environment within cells to balance the 
production of reactive oxygen species and detoxification. Recently, we studied early 
molecular signaling events during oxidative stress in the retina and RPE cells using a 
comparative proteomics approach to identify altered protein levels (Arnouk et al., 2011b; 
Chung et al., 2009b; Lee et al., 2010a; Lee et al., 2010c; Lee et al., 2011; Zhang et al., 
2010b). In RPE cells, one of the downregulated proteins under oxidative stress was 
prohibitin. Changes in the prohibitin level in both diabetic and aging eyes suggest that it 
may have an apoptosis-related function in RPE cells, especially under chronic stress and 
pathophysiological conditions(Lee et al., 2010a). 
 First, we examined the cellular localization of prohibitin, which is a controversial 
question. Translocalization of prohibitin in response to oxidative stress was examined 
using immunocytochemistry. Subcellular organelles and prohibitin were visualized by 
DAPI (nuclear DNA, blue, 369 and 460 nm for absorbance and emission, respectively), 
MitoTracker Orange (mitochondria, red, 578 and 599 nm for absorbance and emission, 
respectively), and Alexa Fluor 488 (prohibitin, green, 495 and 519 nm for absorbance and 
emission, respectively), by taking three color fluorescent images every hour. A kinetic 
assay confirmed that the signaling pathway was involved in the movement of prohibitin 
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to the nucleus from mitochondria. Confluent ARPE-19 cells were treated with 200 μM 
H2O2 for 24 h H2O2 treated cells showed nuclear trans-localization of prohibitin, whereas 
untreated cells showed localization in mitochondria (Figure 1). After 8 h, prohibitin 
showed an accumulation in the nucleus as compared to the control group. After 24 h, 
more nuclear prohibitin was observed and much less co localized with mitochondria.  
 
Figure 2.1 Translocalization of prohibitin under oxidative stress. ARPE-19 cells treated 
with H2O2 (200 μM for 8 or 24 h) were analyzed by immunocytochemistry. Subcellular 
organelles and prohibitin were visualized by DAPI (blue, nucleus), the prohibitin-specific 
primary antibody, the Alexa Fluor 488-conjugated secondary antibody (green, 
prohibitin), and MitoTracker Orange (red, mitochondria). Prohibitin was translocalized 
from mitochondria to the nucleus under oxidative stress in a time-dependent manner. The 
scale bar is 5 μm. 
 
To examine prohibitin response in apoptosis signaling in detail, we then examined 
changes in the protein expression level in vitro using ARPE-19 cells. We examined 
changes in the prohibitin level under H2O2 in a time- and dose-dependent manner. Protein 
analysis by SDS−PAGE and Western blotting demonstrated that prohibitin is down 
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regulated under oxidative stress (200 μM H2O2 for 1−24 h) (Figure 2.2). Cells treated 
with 200 μM H2O2 showed a 40% decrease in their level of prohibitin, but the levels 
between treated groups after 24 h revealed no significant difference by t test, indicating 
that a decreased level of prohibitin caused by oxidative stress is an acute process that 
occurs within 2 h. Down regulation of prohibitin under stress conditions suggests that the 
nuclear prohibitin may not be a newly synthesized protein as there was no increase in the 
level of prohibitin for 24 h; the nuclear prohibitin might derive from mitochondria 
because prohibitin was not colocalized with mitochondria after extended H2O2 treatment.  
 
Figure 2.2 Downregulation of prohibitin under oxidative stress. ARPE-19 cells were 
treated with H2O2. At specific time points, cells were harvested and proteins separated by 
SDS−PAGE. Prohibitin was visualized by Western blotting. The level of prohibitin 
decreased in all treated groups. ANOVA was used to demonstrate the differences among 
groups. Statistical analysis showed that there is a significant difference among groups (P 
< 0.01). Tukey’s Honestly Significant Difference (HSD) test was applied to find the 
source of the difference. Results showed that control group was significantly different 
from the treated groups (4 and 12 h, P < 0.01; 2, 8, and 24 h, P < 0.05). No significant 
difference was found among treated groups. 
 
To address the issue of the membrane binding property of prohibitin in RPE cells, we 
investigated the effect of stress on protein solubility. First, we examined the correlation 
between oxidative stress and soluble prohibitin and found that the ratio of soluble 
prohibitin to membrane binding prohibitin decreased under oxidative stress. Prohibitin 
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exists in both detergent resistant insoluble and soluble fractions and was separated by 
SDS−PAGE using 8 to 16% gradient gels and the maximal running time. Membrane-
binding prohibitin showed slightly higher molecular mass when compared to that of 
soluble prohibitin. As shown in panels A and B of Figure 3, the level of soluble prohibitin 
from ARPE-19 cells decreased and the level of detergent-resistant, membrane-binding 
insoluble prohibitin increased under stress conditions in 4 h. To compare insoluble and 
soluble forms from subcellular organelles, we separated prohibitins from mitochondria 
(M), cytosol (CYT), and whole cell lysate (WCL) by SDS−PAGE and visualized them by 
Western blotting (Figure 3C). Soluble prohibitin from ARPE- 19 cells in the cytosolic 
fraction (32 kDa) moved faster than membrane-bound mitochondrial and microsomal 
prohibitin (34 kDa). The insoluble, detergent-resistant, membrane binding prohibitin 
exhibited a slightly higher-molecular mass band compared to that of cytosolic, soluble 
prohibitin. Prohibitins in whole cell lysate from both retinal and RPE cells showed two 
bands as insoluble and soluble forms. It is possible that the membrane-binding and 
soluble prohibitins may exist in different subcellular organelles, so we next examined the 





Figure 2.3 Detergent-resistant membrane prohibitin under oxidative stress.  (A)  
Detergent-resistant (insoluble) and soluble prohibitins were separated by SDS−PAGE 
and visualized by Western blotting. Under oxidative stress (OS, 250 μM H2O2, 4 h), 
detergent-resistant prohibitin was upregulated compared to the control. (B) Quantitative 
analysis of insoluble and soluble prohibitin under oxidative stress. (C) Prohibitins from 
bovine retinal cells and ARPE-19 cells were compared for the analysis of insoluble and 
soluble forms. Mitochondrial prohibitin (M) moved slightly slower than the cytosolic 
form (CYT). Whole cell lysate (WCL) from both bovine retinal cells and ARPE-19 cells 
shows detergent-resistant insoluble and soluble forms of prohibitin. 
 
2.4.2 Subcellular Localization of Prohibitin in the Retina and RPE Cells 
Our previous experiments demonstrated that prohibitin may respond differently in the 
retina and RPE cells under various oxidative stress conditions, including diabetes and 
aging. To specify the location of prohibitin in the retina, we fractionated bovine retina 
using serial centrifugation and specific detergents, including polyamines (Cox and Emili, 
2006a). Via this method, proteins were separated by nuclear and mitochondrial extraction 
buffer. Denatured and native gel electrophoresis and Western blotting of the subcellular 
organelle showed that prohibitin is widely distributed in retina cells but centralized in 
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mitochondria (Figure 2. 4). We used cytochome c, RNA polymerase II, and transketolase 
as positive controls to show mitochondrial, nuclear, and cytosolic fractions, respectively. 
Quantitative analysis showed that 60−80% of prohibitin in bovine retina was localized in 
the mitochondrial membrane pellet (Figure 2.4, Mitochondria II) in bovine retina cells, 
but the cytosol and nucleus (soluble I and membrane II) also contain a substantial amount 
of prohibitin. Then we explored the prohibitin levels in different subcellular locations in 
RPE cells. Our fractionation experiments using ARPE-19 cells showed that prohibitin has 
a membrane-binding and soluble form. In ARPE-19 cells, prohibitin was mainly 
expressed in mitochondria (60−80%) as determined by the Cox fractionation method 
(Cox and Emili, 2006a). 
 
Figure 2.4 Subcellular localization of prohibitin. Subcellular fractions were separated by 
the Cox and Emili method. Proteins in the retina were fractionated on the basis of serial 
centrifugations with extraction buffers and separated by SDS−PAGE. The prohibitin 
concentration was quantitatively analyzed. Prohibitin in bovine retina was localized 
mostly in mitochondria as a membrane-associated form (II, mitochondrial membrane) 
rather than a soluble form (I, mitochondrial matrix). Prohibitin was also detected in the 
nucleus. The relative amounts of prohibitin are presented as matrix (I) and membrane (II) 
in mitochondria, nucleus (supernatant I and membrane-associated II), cytosol, and 
microsome. 
          As prohibitin is widely spread in each subcellular fraction, we asked whether 
different subcellular prohibitins have the same isoelectric point (pI). We used 2D 
electrophoresis to isolate prohibitin from the fractionated subcellular proteome. 
Mitochondrial, nuclear, cytosolic, and microsomal prohibitin were separated and 
visualized by Coomassie staining and Western blotting (Figure 2.5). In the mitochondrial 
fraction, prohibitin exhibited a molecular mass of 32 kDa and a pI of 5.6 as expected. 
Prohibitin was more acidic in the nucleus, with a pI of 5.3, because of post-translational 
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modifications such as phosphorylation. Cytosolic prohibitin showed very basic spots of 
pI 6-7 and a higher molecular mass as shown in the box, representing potential 
ubiquitination. As each subcellular prohibitin exhibited different pI values in 2D 
electrophoresis, we examined potential post-translational modifications in bovine retinal 
cells, including phosphorylation, using a different fractionation method (Cox and Emili, 
2006a). Mitochondrial and nuclear fractions were further separated by matrix (Mito I and 
Nucl I) versus membrane (Mito II and Nucl II) proteins. Prohibitin in the mitochondrial 
matrix (Figure 2. 6, lane 1) and cytosol (Figure 2.6, lane 5) may exist as a putative 
heterodimer at 75 kDa, whereas it showed multiple bands around 32 kDa in the nucleus 
and cytosol, possibly because of  phosphorylation or peripheral membrane interactions. 
Proteins in each fraction were separated by electrophoresis, and prohibitin was visualized 
by Western blotting using prohibitin and phosphatidylserine (p-Ser) antibodies. Only the 
nuclear fraction exhibited phosphorylated prohibitin demonstrated by p-Ser Western blot 
(Figure 2.6, lanes 9 and 10). Mitochondrial, cytosolic, and microsomal prohibitins did not 
show phosphorylation. To confirm these data, we performed native gel electrophoresis 
and produced the same result (Figure 2.6, lanes 9 and 10). Mass spectrometry (MALDI-





Figure 2.5 2D SDS−PAGE analysis of prohibitin. Each fraction from bovine retinal cells 
was separated by isoelectric focusing and gel electrophoresis. Prohibitin was visualized 
by Western blotting. The nuclear fraction showed phosphorylated prohibitin as one acidic 
spot at pI 5.3 shown by the arrow, whereas many modified prohibitin spots in the box 




Figure 2.6 Phosphorylation of prohibitin in the nucleus. (A) Each fraction was further 
separated by SDS−PAGE and phospho-Western blotting. Prohibitin in the mitochondrial 
matrix (I) and cytosol shows a putative heterodimer at 75 kDa under denaturing 
conditions, whereas nuclear prohibitin (supernatant I and membrane II) shows multiple 
bands due to modifications and membrane association. Prohibitin in the nuclear fraction 
was phosphorylated as shown by using the p-Ser antibody (lanes 9 and 10). (B) Proteins 
were separated by native gel electrophoresis, and prohibitin was visualized by Western 
blotting using the anti-prohibitin primary antibody and p-Ser antibody. Prohibitin in the 
nucleus is phosphorylated as shown in lanes 9 and 10. Prohibitin may exist as a 
heterodimer or oligomer as shown in lane 2 (mitochondrial membrane, 50, 150, and 750 
kDa), lane 3 (nuclear supernatant, 150 kDa), lane 5 (cytosol, 75 and 150 kDa), and lane 6 
(microsome, 150 kDa). 
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2.4.3 Prohibitin Binds Cardiolipin under Oxidative Stress 
We next asked whether prohibitin localization could be controlled by membrane lipid 
binding. Considering mitochondrion- specific lipid composition, we speculated that the 
localization and trafficking of prohibitin might be determined by a mitochondrion-
specific lipid such as cardiolipin. Prohibitin in the bovine retina binds with cardiolipin, a 
major mitochondrial phospholipid (Figure2.7A). The lipid interaction assay demonstrated 
that mitochondrial prohibitin from bovine retina has a strong affinity at relatively low 
cardiolipin concentrations (10−15 μg, 6−10 nmol), whereas nuclear prohibitin showed a 
weaker affinity for cardiolipin (Figure 2.7). However, prohibitins in RPE cells showed 
different lipid interactions under oxidative stress when we examined prohibitin using 
ARPE-19 cells. Under normal conditions, prohibitin from ARPE-19 cells demonstrated a 
strong interaction with phosphatidylinositol 3,4,5-triphosphate (PIP3)  but not with 
cardiolipin (Figure 2.8). The lipid binding affinity changed dramatically under oxidative 
stress induced by H2O2 (200 μM). Prohibitin under stress showed a strong affinity for 
cardiolipin as shown in Figure 2.8. This observation led us to conclude that prohibitin has 
an affinity for negatively charged phospholipids, especially cardiolipin. Lipid analysis by 
mass spectrometry demonstrated that the cardiolipin concentration decreased 20−70% 









Figure 2.7 Prohibitin−cardiolipin interactions. (A) Prohibitin in the nucleus and 
mitochondria from bovine retina showed different cardiolipin affinities depending on the 
cardiolipin concentration. (B) Quantitative analysis of prohibitin−cardiolipin binding. 
Data for mitochondrial prohibitin (■) and nuclear prohibitin (●) are shown. The Y-axis 






Figure 2.8 Fractionated or IP-purified proteins were incubated with the nitrocellulose 
membrane coated with various lipids. The membrane was incubated with 
immunoprecipitated prohibitin, and the lipid- prohibitin interaction was visualized by 
Western blotting. Prohibitin-lipid binding was changed under oxidative stress (200 μM 
H2O2). Under normal conditions, prohibitin interacts with phosphatidylinositol 
phosphates (PIP3), whereas under oxidative stress, prohibitin binds with cardiolipin. 
 
2.4.4 Anti-Apoptotic Prohibitin Function in Mitochondria 
We performed a loss of function study with prohibitin-specific small interfering RNA 
(siRNA), resulting in an increase in the level of apoptotic signaling at decreased 
prohibitin levels (Figure 2.9). We tested two siRNA constructs that inhibit prohibitin 
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expression against a control siRNA that has a random sequence. A solvent vehicle was 
used as a negative control. We chose conditions under which the levels of prohibitin 
expression were reduced by 80−90% when compared to the random sequence control. 
We examined whether anti-apoptotic molecules such as BCL-xL and proapoptotic 
molecules that include apoptosis inducing factor (AIF), caspases, and BCL-2 homologous 
antagonist/killer (BAK) are also activated as essential markers in apoptosis (Figure 2.9). 
The activation of AIF and caspase-9 cleavage, the upstream regulators in apoptosis, 
showed early apoptotic signaling under prohibitin knockdown conditions. However, the 
level of anti-apoptotic BCL-xL decreased when prohibitin was downregulated. Further, 
we investigated whether prohibitin knockdown cleaves poly(ADP ribose) polymerase 
(PARP) as a pro-apoptotic marker. PARP cleavage is an early marker of caspase 
activation. Transfection of siRNA of prohibitin into ARPE-19 cells resulted in an 
increased level of cleavage of PARP, which represents the fact that an apoptotic signal is 
induced when prohibitin is downregulated (data not shown). Our results demonstrate that 
knockdown of prohibitin increases the strength of apoptotic signaling. These observations 
suggest that prohibitin may act as an anti-apoptotic protein in mitochondria by forming a 
functional complex with apoptotic proteins. The prohibitin concentration is inversely 
correlated with the initiation of apoptosis. Then we examined whether a decreased level 
of prohibitin disrupts the filamentous reticular network of mitochondria and results in 
fragmented mitochondria. Immunocytochemical analysis showed that prohibitin 
knockdown led to accumulation of fragmented mitochondria as shown in Figure 2.9B. 
Fragmented mitochondria imply that the fusion of mitochondrial membranes is impaired 





Figure 2.9 Anti-apoptotic prohibitin shown by knockdown analysis. (A) ARPE-19 cells 
were transfected by siRNA and random sequence. The level of anti-apoptotic BCL-xL 
increased when prohibitin was downregulated. Pro-apoptotic proteins, including AIF, 
caspase-9, and BAK, were upregulated under prohibitin knockdown conditions. (B) 
ARPE-19 cells under siRNA or random sequence were analyzed by 
immunocytochemistry. Prohibitin, mitochondria, and the nucleus were visualized by 
Alexa Fluor 488 (green), MitoTracker Orange (red), and DAPI (blue), respectively. 
When prohibitin was downregulated by siRNA, the mitochondrial structure was 




2.4.5 Prohibitin Function in the Nucleus 
To address a putative functional role of prohibitin in the nucleus, protein- protein 
interaction was examined. Immunoprecipitation of prohibitin demonstrated that 
prohibitin is involved in direct regulation of transcription through p53 binding. The 
prohibitin−protein binding assay using the anti-prohibitin primary antibody, followed by 
SDS−PAGE, and mass spectrometry demonstrated that prohibitin has interactions with 
transcription factors that include tumor suppressor p53. A Western blot of 
immunoprecipitated fractions confirmed prohibitin-p53 interaction as shown in Figure 
2.10. To test oxidized cardiolipin-dependent translocalization, we examined a known 
cardiolipin antioxidant etoposide. Etoposide is an antitumor drug that acts as a 
topoisomerase II inhibitor and is used to block cardiolipin oxidation and prohibitin 
translocalization. Treatment for 1 h induced translocalization of prohibitin from the 
nucleus to the cytosol.  
 
Figure 2.10 Binding of prohibitin to p53. Immunoprecipitation using the prohibitin 
antibody demonstrated the interaction between prohibitin and p53. The purified anti-
prohibitin antibody was immobilized with amino-linked protein A and washed. Protein 
samples were incubated in the protein A−antibody column with gentle mixing overnight 
at 4 °C. Columns were washed three times to remove nonspecific binding proteins. 
Eluted fractions were separated by SDS−PAGE and visualized by western blotting using 
primary antibodies against prohibitin and p53. 
 
2.5 Discussion 
In this study, we demonstrate that prohibitin is translocalized from mitochondria to the 
nucleus as a mitochondrial response to oxidative stress in vitro. Previously, we 
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investigated oxidative stress-induced proteome changes in RPE cells using the 
differential gel electrophoresis (DIGE) technique to identify early biomarkers of eye 
diseases (Lee et al., 2010a; Ryan and Hoogenraad, 2007). We were seeking a novel 
protein that shuttles between mitochondria and the nucleus as the initiation step in retinal 
pathogenesis. We found that prohibitin changes its subcellular location under stress 
conditions. In this study, dynamic translocalization of prohibitin was examined by 
subcellular fractionation, immunocytochemistry, a lipid binding assay, and a knockdown 
approach. This study challenges a question of mitochondrial−nuclear (MT-NU) 
communication by protein translocalization through the lipid interaction change 
mechanism. Knockdown and immunoprecipitation studies suggest that trafficking 
prohibitin may have a dual function as an anti-apoptotic molecule that maintains 
mitochondrial structure and as a transcriptional activator that interacts with p53 in the 
nucleus. We tested the hypothesis that a lipid binding property of prohibitin may 
determine mitochondrial localization. As prohibitins are expected to be dynamically 
translocated within retinal and RPE cells, there is an essential need for a time-dependent 
assay of cellular prohibitin movement. Under oxidative stress, the level of cardiolipin 
decreased and the level of cardiolipin-prohibitin interactions increased. At relatively low 
cardiolipin concentrations (<6−10 nmol), mitochondrial prohibitin competes with nuclear 
prohibitin for cardiolipin binding. We examined whether levels of prohibitin in 
mitochondria and the nucleus are altered by oxidative stress. We found that the level of 
prohibitin initially decreased by mild oxidative stress with H2O2 treatment especially at 
the IC50 concentration (Chung et al., 2009b; Lee et al., 2010a). Translocalization of 
prohibitin under stress conditions led us to investigate post-transcriptional regulation. A 
proteomics approach using SDS−PAGE and phosphor-Western blotting demonstrated 
that soluble nuclear prohibitin is phosphorylated. Gel electrophoresis under denatured or 
native conditions showed that prohibitin may exist as a heterodimer, soluble, membrane-
associated, and post-translationally modified form in different subcellular organelles. 
Upregulation of pro-apoptotic molecules and down regulation of anti-apoptotic proteins 
under prohibitin depletion by siRNA suggest an anti-apoptotic response of prohibitin 
depending on the prohibitin levels. To maintain mitochondrial integrity, nuclear and 
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mitochondrial genes should communicate with each other, especially under stress 
conditions that include hypoxia, abnormal temperature, nutrient deficiency, and aging. 
Our results suggest that prohibitin may fulfill dual roles as a phospholipid scaffold switch 
and an MT−NU shuttle under stress conditions in the retina and RPE cells. Coordinated 
prohibitin−lipid interactions, including cardiolipin and PIP3, support the phospholipid 
scaffold switch mechanism hypothesis (Osman et al., 2009; van Gestel et al., 2010). 
Cardiolipin, a negatively charged diphosphatidylglycerol-derived phospholipid, is mainly 
localized in mitochondria and plays a significant role in maintaining mitochondrial 
membrane function and structure. The level of cardiolipin decreases with aging and is 
involved in the upregulation of mitochondrially derived reactive oxygen species. 
Considering cardiolipin’s role in mitochondria, it is reasonable to speculate that 
cardiolipin composition may affect targeted trafficking of mitochondrial proteins, 
especially under oxidative stress. The age-related decrease in the level of cardiolipin is 
correlated with increased cholesterol: phospholipid ratio (Shigenaga et al., 1994a). 
Cholesterol depletion using β-cyclodextrin and simvastatin upregulated prohibitin 
expression, and cholesterol treatment decreased the level of prohibitin in ARPE-19 cells 
(data not shown). Post-translational modifications that include hydrophobic 
palmitoylation and negatively charged phosphorylation may affect membrane binding 
and translocalization in subcellular organelles (Ande and Mishra, 2010; Lee et al., 2010b; 
Morrow et al., 2002; Xue et al., 2004). Consistent with our results, recent studies using 
proapoptotic peptide targeting prohibitin demonstrated that prohibitin might be connected 
to upregulation of lipid turnover and an increased metabolic rate (Kolonin et al., 2004a). 
Changes in cellular metabolism are a central hallmark in the aging process in the retina 
and RPE cells. When apoptosis was induced by prohibitin-peptide binding, it was shown 
that the levels of lipid metabolism, energy expenditure, oxygen consumption, and heat 
generation increased. Using Caenorhabditis elegans as a model system, it was reported 
that prohibitin depletion affected ATP levels, lipid content, and mitochondrial 
proliferation in an age-specific manner (Artal-Sanz and Tavernarakis, 2009b). Our results 
support the hypothesis that prohibitin may have a similar role in modulating 
mitochondrial structure by binding cardiolipin to maintain mitochondrial integrity under 
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stress conditions. This study also demonstrated that prohibitin expression levels may 
determine the mitochondrial morphology and distribution as shown by the knockdown 
approach. Recent studies examined the versatile functions of prohibitin as a drug 
resistance mediator, plasma membrane receptor, obesity regulator, and cancer target 
(Artal-Sanz and Tavernarakis, 2009b; Gregory-Bass et al., 2008; Ko et al., 2010; Nuell et 
al., 1991; Patel et al., 2010; Terashima et al., 1994; Zubovych et al., 2006). A metabolic 
switch mechanism of prohibitin was shown by pyruvate carboxylase inhibition and PIP3 
binding (Ande and Mishra, 2009). Prohibitin may modulate glucose and fatty acid 
oxidation by balancing between oxidative phosphorylation and anaerobic glycolysis 
under rapid proliferation, which are associated with malignant transformation (Mishra et 
al., 2006). Down regulation of prohibitin may activate a retrograde communication that 
induces mitochondrial proliferation and an increased level of reactive oxygen species 
(ROS) (Artal-Sanz and Tavernarakis, 2009a; Artal-Sanz et al., 2003; Coates et al., 1997; 
Fusaro et al., 2003b; Ikonen et al., 1995; Rajalingam et al., 2005; Sanchez-Quiles et al., 
2010; Shigenaga et al., 1994b). A functional role for prohibitin in the nucleus was 
suggested as a transcriptional regulator by observation of its interactions with p53, E2F, 
and Rb (Fusaro et al., 2003a). In cancer cells, prohibitin is localized in the nuclear matrix 
(Shi et al., 2009). Cholesterol-induced downregulation of prohibitin was shown as a 
regulator of cell cycle transit in the nucleus (Dong et al., 2010; Sanchez-Quiles et al., 
2010). Our previous study suggested that NF-κB was translocated into the nucleus under 
oxidative stress, and protein translocalization may act as a cell survival mechanism under 
stress conditions (Lee et al., 2010a). Nuclear tumor suppressor p53 also translocalized 
into mitochondria under apoptotic conditions. The coordinated translocalization of 
prohibitin may determine cell viability and the apoptotic cell population in the retina and 
RPE cells. Prohibitin under oxidative stress and altered lipid environments may regulate 
the cell survival or death pathway by changing protein−lipid interactions. In the 
beginning of retinal degeneration, prohibitin may act as anti-apoptotic molecules as the 
default function in mitochondria, whereas it may become a transcriptional regulator under 
prolonged or repeated stress conditions. This dual function of prohibitin might be the 
essential mechanism for controlling apoptotic signaling as a cell fate determinant from 
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uncontrolled proliferation as suggested by the conserved gene evolution in an oxidative 
environment (Di et al., 2010). 
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      Light is a risk factor for various eye diseases, including age-related macular 
degeneration (AMD) and retinitis pigmentosa (RP). We aim to understand how 
cytoskeletal proteins in the retinal pigment epithelium (RPE) respond to oxidative stress 
and how these responses affect apoptotic signaling. Previously, proteomic analysis 
revealed that the expression levels of vimentin and serine/threonine protein phosphatase 
2A (PP2A) are significantly increased when mice are exposed under continuous light for 
7 days compared to a condition of 12h light/dark cycling exposure using retina 
degeneration 1 (rd1) model. When melatonin is administered to animals while they are 
exposed to continuous light, the levels of vimentin and PP2A return to a normal level. 
Vimentin is a substrate of PP2A that directly binds vimentin and dephosphorylates it. The 
current study shows that upregulation of PP2Ac (catalytic subunit) phosphorylation 
negatively correlates with vimentin phosphorylation under stress condition. Stabilization 
of vimentin appears to be achieved by decreased PP2Ac phosphorylation by nitric oxide 
induction. We tested our hypothesis that site-specific modifications of PP2Ac may drive 
cytoskeletal reorganization by vimentin dephosphorylation through nitric oxide signaling. 
We speculate that nitric oxide determines protein nitration under stress conditions. Our 
results demonstrate that PP2A and vimentin are modulated by nitric oxide as a key 
element involved in cytoskeletal signaling. The current study suggests that external stress 
enhances nitric oxide to regulate PP2Ac and vimentin phosphorylation, thereby 
stabilizing or destabilizing vimentin. Phosphorylation may result in depolymerization of 
vimentin, leading to nonfilamentous particle formation. We propose that a stabilized 
vimentin might act as an anti-apoptotic molecule when cells are under oxidative stress. 
3.2 Introduction 
Intense light kills retinal and RPE cells through irreversible apoptotic reactions (Adrian et 
al., 1977; Grimm et al., 2002; Grimm et al., 2000; Noell et al., 1966; Young, 1988). 
Paradoxically light may protect the retina and RPE by controlling expression of anti-
apoptotic and anti-oxidative molecules, including erythropoietin, thioredoxin (THR), and 
heme oxygenase-1 (HO-1) (Grimm et al., 2002). Excess light may trigger circadian-
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dependent pathologic signals and oxidative stress by changing expression of proteases or 
proteins in the visual cycle that include caspases, rhodopsin, cellular retinaldehyde 
binding protein (CRALBP), and RPE65 (Chung et al., 2009b; Lee et al., 2010c; Zhang et 
al., 2010b). The mechanism of oxidative stress-induced apoptosis still remains elusive, 
but our previous proteomics approach implies that the protein expression profile, 
including BCL-xL, prohibitin, and vimentin, might be involved in the initiation of 
apoptosis as a positive or negative signal (Arnouk et al., 2011b; Chung et al., 2009b; 
Zhang et al., 2010b). Our studies suggest that the balance between anti- and pro-apoptotic 
proteins as well as the balance between oxidative stress and anti-oxidative shield may 
determine the cell fate based on external light/dark cycle environment. Apoptotic cell 
death induced by intense or constant light in the retina and RPE may lead to major 
diseases that cause blindness, including AMD and RP (Grimm et al., 2002; Grimm et al., 
2000). Retinal and RPE cells have chromophores, including rhodopsin, peropsin, and 
retinal G protein receptor (RGR) that contain 11-cis-retinoid that can be isomerized by 
photons. Rhodopsin is a mediator of intense light-induced apoptosis and the activation of 
the transcription factor AP-1 complex (c-Fos/Jun) acts as a central downstream pathway 
for light-induced apoptosis. However, the mechanism by which light causes 
morphological alterations that initiate the death signal is elusive. Lack of such knowledge 
is an important issue, because without it, acquiring the ability to modulate cellular 
protection is highly unlikely. Thus there is an urgent need for the understanding of the 
molecular and biochemical mechanisms involved in light-induced cytoskeletal changes. 
Our previous studies suggest that post-translational nitration or phosphorylation may 
regulate cytoskeletal reorganization and protein trafficking under oxidative stress 
(Arnouk et al., 2011b; Chung et al., 2009b; Lee et al., 2010c; Sripathi et al., 2011c; Zhang 
et al., 2010b). Nitric oxide (NO) is a highly reactive free-radical gas that is involved in 
the expression of erythropoietin receptors (EPOR) in neurons from mouse brains (Chen et 
al., 2010; Genc et al., 2001). Recent studies suggest that NO plays a specific role in the 
protective pathway; however, it is nearly impossible to establish optimal levels of NO 
efficacy using current techniques. Clearly defining how much NO is needed and for what 
duration it is produced to induce up-regulation of protein phosphorylation is critical 
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because excess levels of NO is toxic and will lead to tissue damage and cell death 
(Karnovsky, 1985; Sortino, 2010; Sugimoto et al., 2000). In the current study, NO 
produced by cells was detected continuously in situ using a chemiluminescence reaction 
between NO and ozone. We aimed to establish therapeutic levels of NO that induces up-
regulation of protecting molecules. The objective of our study is to answer the question 
whether NO prevents retinal degeneration by inducing or inhibiting phosphorylation 
signaling of target proteins. To attain the objective of this aim, we tested the working 
hypothesis that NO may have a dual role as a physiological neuroprotectant and a 
pathological cytotoxic compound depending on concentration and location. The levels of 
NO produced by RPE cells were directly measured under different levels of light or 
oxidative stimulation. We have quantitatively established what level and duration of NO 
accounts for its protective properties and at what level NO becomes pathological in RPE 
cell death. Our results suggest that NO is generated in RPE cells under various oxidative 
stress conditions in a time-dependent manner. Appropriate levels of NO control 
phosphorylation of vimentin and PP2A in the RPE that may lead to regulate stress-
dependent apoptotic pathways. 
3.3 Material and methods 
3.3.1 ARPE-19 Cell Culture 
Human retinal pigment epithelial cells (ARPE-19) were obtained from American Type 
Culture Collection (Manassas, VA). Cells were cultured in 25 cm2 flask (Corning, St. 
Louis, MO) or 56.7 cm2 dishes (Nunc, Naperville, IL) containing Dulbecco’s modified 
Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (Sigma, St. Louis, 
MO) and 1% penicillin/ streptomycin (Hyclone, Logan, UT). Cells were maintained in 
humidified 5% CO2 incubator at 37 °C. 
3.3.2 Light, oxidative stress, reoxygenation, and LPS treatment 
Confluent ARPE-19 cells were exposed to bright fluorescent light (7000 lux), tert-butyl 
hydroperoxide (200 μM), reoxygenation (2 hrs hypoxic condition by N2 then 21% O2) 
and LPS (5-10 μg/mL) in serum free medium for different time intervals in CO2 incubator. 
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Cells grown in 25 cm2 flasks were used to measure NO release in situ. Cells were 
harvested to extract total proteins using ice cold 1X RIPA lysis buffer [0.5 M Tris-HCl 
(pH 7.4), 1.5 M NaCl, 2.5% deoxycholic acid, 10% NP-40, and 10 mM EDTA (Millipore, 
Darmstadt, Germany)] containing protease inhibitor cocktail (Pierce, Rockford, IL). Cell 
lysates were centrifuged at 10,000 x g for 30 min at 4 °C to pellet cell debris. Proteins 
were separated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS−PAGE), followed by Western blotting analysis. 
3.3.3 Direct NO measurement  
NO release from ARPE-19 cells was measured via chemiluminescence detection with 
Sievers 280i Nitric Oxide Analyzer (GE Instruments, Boulder, CO) using 200 mL/min 
ambient air with added 5% CO2 sweep gas. NO analyzer was equilibrated with 5% CO2 
incubator for 30 minutes before the experiment. Prior to NO analysis, the instrument was 
calibrated three times using NO (45 PPM) and air by passing through a Sievers NO zero 
filters, followed by zero calibration. Confluent cells grown in T25 flask under oxidative 
environment (light; exposed to 7000 lux of fluorescent light, oxidative stress; treated with 
200 μM of t-butyl hydroperoxide, reoxygenation; 21% O2 added at 2 hrs, LPS; treated 
with 5μg/mL of LPS) were directly connected to Nitric Oxide Analyzer using custom 
made adaptor.  The amount of released NO is measured in PPB (parts per billion) and is 
converted to mole per surface area by a calibration factor (nmole·cm-2·min-1) then 
represented by graphs using MATLAB software. To determine intracellular NO 
formation using a fluorescent molecule, cells were incubated in media containing 4,5-
diaminofluorescein-2-diacetate (DAF-2DA, 5μM, Sigma) for 15 min after stress 
treatment (12,000 lux light, 24 hrs). After washing three times with PBS, cells were fixed 
with 2% glutaraldehyde for 3 min. Images were acquired using Zeiss Axiovert 200M Apo 
Tome fluorescent microscope with 63 X magnifications.   
3.3.4 SDS-PAGE and Western Blot analysis 
   Proteins were quantified using BCA protein assay kit (Pierce) based on the 
manufacturer’s protocol by plotting BSA standard curve.  Samples were dissolved in 4X 
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Laemmli sample buffer (240 mM Tris pH 6.8, 8% SDS, 40% glycerol, 0.4% 
bromophenol blue, 10% β- mercaptoethanol), heated at 90°C for 10 min. Proteins were 
resolved using 10% or 8-16% gradient polyacrylamide precast gels (Bio-Rad), followed 
by electrotransfer on to the methanol activated PVDF membrane (Bio-Rad) via semidry 
transfer by applying 20V for 30 min. Non-specific proteins were blocked for 1 hr at 4°C 
with 5% nonfat dry milk (Bio-Rad) prepared in TBS with 0.1% (v/v) Tween-20.  
Membranes were probed with primary antibodies (Santa Cruz Biotechnology Inc, CA), 
including iNOS (sc-651; 1:100), Nitrotyrosine (sc-32731; 1:25), p-vimentin (sc-16673; 
1:500), p-PP2Ac (sc-12615; 1:500), Bcl-xL (sc-634; 1:500) and β-actin (sc-47778; 
1:1000) at 4 °C for overnight and subsequently incubated with corresponding horse 
radishperoxidase conjugated secondary antibodies for 2 h at room temperature. 
Membranes were developed with West Pico Chemiluminescent Substrate (Pierce) for 2 
min and immunoreactive protein bands were visualized using a LAS 4000 mini 
luminescent image analyzer (GE, Piscataway, NJ). Bands were quantified based on pixel 
size/intensity/area using Quantity One software (Bio-Rad) and graphs were plotted based 
on relative intensity of bands using GraphPad Prism software.  
3.3.5 Immunocytochemistry 
ARPE-19 cells were seeded on sterile glass cover slips placed in 6 well plate (Nunc, 10 
cm2 per well) with serum containing DMEM/F12 media supplemented with  1% 
penicillin–streptomycin (Hyclone) 5% CO2 incubator at 37 °C. Cells were treated with 
200 μM of tert-butyl hydroperoxide for 36 or 48 h to induce oxidative stress. Cells were 
fixed with 10% formaldehyde in PBS for 30 min at RT. After fixation, cells were 
incubated in 0.2% Triton X-100 (Sigma) for 25 min to permeabilize cell membrane and 
blocked with complete media containing 10% FBS and 0.05% Tween-20 (Sigma) for 1 hr 
and probed with anti-iNOS, anti-vimentin antibody (1:100; Santa Cruz) for overnight at 
4 °C. Subsequently, cells were stained with Alexa Fluor 488- conjugated anti-rabbit IgG 
(1:700, Molecular Probes) for 2 hrs at RT. Finally, immunostained samples were mounted 
using Vectashield (Vector Laboratories, Burlingame, CA) mounting medium containing 
DAPI (4, 6-diamidino-2-phenylindole) to counterstain the nucleus. Images were captured 
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using fluorescent microscope (Zeiss AxioVert 200 M Apo Tome) with 20X magnification.  
3.3.6 Scanning Electron Microscopy (SEM) 
ARPE-19 cells were cultured on coverslips in 6 well plate (Nunc, 10 cm2 per well).  Cells 
were treated with 100 μM of H2O2 in serum free media for 2 hrs to induce oxidative 
stress. Sample preparation protocol was followed as previously reported(Karnovsky, 
1985). After brief wash with PBS, cells were immersed immediately into fixative solution 
containing 3% paraformaldehyde and 0.1% glutaraldehyde in phosphate buffer (pH 7.1) 
at RT for 1 hr.  Samples were removed from the fixing solution and washed three times 
with PBS and then post fixed in 1% osmium tetroxide in 0.2M phosphate buffer. After 
three additional brief washings in distilled H2O, cells were dehydrate in a graded EtOH-
H2O series and then critical-point-dried in a CO2 chamber. Cells were coated with a 10 
nm layer of platinum-palladium alloy in a vacuum evaporator to examine in the scanning 
electron microscope (JEOL JSM-6400) at 4000X magnification.  
3.4 Results  
3.4.1 NO Production in the RPE under Oxidative Stress 
To address the issue of the protective and pathological roles of NO in neurodegeneration, 
we directly measured NO produced by RPE cells exposed to different stresses. First we 
asked how much NO is generated and what duration it is produced under various 
environmental stimuli. We aimed to establish therapeutic or cytotoxic levels of NO that 
induce up-or down-regulation of phosphorylation signaling of vimentin and PP2A. NO 
produced by RPE cells were determined in situ after exposure to each of following: dark, 
light, oxidative stress, reoxygenation, and lipopolysaccharide (LPS) as shown in Figure 
3.1A.  Cells exposed to dark conditions did not show any detectable increase of NO 
levels.  Cells treated with light (7000 lux) showed an increase in NO concentration after 
19 hrs of exposure.  Cells treated with 200 μM  tert-butyl hydroperoxide (t-BuOOH, 
oxidative stress) showed  an increase in NO concentration at 16, 18, and 20 hrs.  Based 
on the observation of the increased levels of NO, oxidative stress and light play a positive 
regulatory role in the production of NO by ARPE-19 cells. NO generation positively 
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correlates with our Western blotting analysis of iNOS under light and oxidative stress.  
Cells treated with reoxygenation after hypoxic conditions (nitrogen stream for 2 hours) 
before being exposed back to normoxia (21% O2) showed the greatest elevation in NO 
production, immediately after reoxygenation at 2 hrs and remained active for 20 hrs.  












Figure 3.1 A. Dark, light, oxidative stress, reoxygenation, and LPS induced NO 
production in vitro.  Confluent ARPE-19 cells cultured in T-25 flasks were incubated 
under intense light (7000 lux), oxidative stress (200 μM t-BuOOH), reoxygenation 
(hypoxia by N2 flow for 2 hrs then 21% O2) and lipopolysaccharide (5 μg/mL) in 
humidified 5% CO2 chamber. Released NO from cells was detected each second for total 
24 hrs using Nitric Oxide Analyzer 280i. NO released from cells reacts with ozone to 
produce NO2 and a photon as a chemiluminescence signal which is proportional to NO 
concentration. X-axis represents time (hrs) and Y-axis represents concentration in parts 
per billion (PPB). B. Quantitative analysis of NO released (PPB) and NO surface flux 
(nmole/(min*cm^2)) under intense light, oxidative stress, reoxygenation, and 
lipopolysaccharide condition. C. Light induced NO detection by 4, 5-diaminofluorescein 
diacetate (DAF-2DA). ARPE-19 cells were treated with the dark or intense light (12,000 
lux) conditions. Cells were incubated with 5 μM 4, 5 diaminofluorescein diacetate (DAF-
2DA) (excitation at 470 to 490 nm and emission at 515 nm, green) for 15 min followed 
by fixation with 2% glutaraldehyde to detect NO levels under light induced stress.  
       As a positive control for NO production, cells were treated with LPS (5μg/mL), 
which also stimulated secretion of NO.  NO secretion occurred at 12, 17, 19.5, and 23 
hours.  This was the most significant increase in NO secretion for any of the conditions 
tested. A quantitative analysis of NO release is shown in Table 1.1. Light induced 
intracellular NO in the RPE was detected using 4, 5-diaminofluorescein 2- diacetate 
(DAF-2DA) as shown in Figure 3.1B.  Detection of intracellular NO in living cells using 
DAF-2DA is a recently developed method in combination with aldehyde fixation. Our 
fluorescent analysis illustrated that RPE cells exposed to intense light (12,000 lux) 
generated higher levels of intracellular NO compared to dark control. The control in the 
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dark did not show any detectable fluorescence, provides the direct evidence that RPE 
cells under intense light generate NO. 
3.4.2 Treatment with LPS, tert-butyl hydroperoxide (t-BuOOH) and light 
upregulates inducible nitric oxide synthase (iNOS) in the RPE 
Since NO generation is controlled by iNOS, expression changes of iNOS in response to 
external stimuli were analyzed by Western blotting.  As shown in Figure 3.2A, LPS, 
oxidative stress, and light treatment significantly upregulated iNOS expression in RPE 
cells in concentration or time-dependent manner. Levels of iNOS expression are also 
consistent with NO production in RPE cells.  iNOS is responsible for the conversion of 
L-arginine to NO and citrulline in the cell.  ARPE-19 cells were treated with light (7,000 
lux) for 12 and 18 hours, as well as a control that had no light exposure (Figure 3.2B).  
Light exposed cells had higher levels of iNOS expression compared to time 0 controls, 
with 18 hrs having a higher concentration than 12 hrs and the control showed no visible 
band of iNOS.  Another group of ARPE-19 cells were treated with oxidative stress in the 
form of 200 µM t-BuOOH, or LPS at either 5 or 10 µg/mL.  A control sample showed no 
iNOS at 130 kDa, while the samples treated with oxidative stress and LPS showed iNOS, 
suggesting an upregulation of iNOS due to these conditions.  LPS exposure caused the 




Figure 3.2 Expression of inducible nitric oxide synthase (iNOS) under LPS, oxidative 
stress and light treatment.  ARPE-19 cells were treated with LPS (5 or 10 μg/mL for 24 
hrs), tert-butyl hydroperoxide (200 μM for 24 hrs), and intense light (1000 lux for 24 
hrs). Cells were harvested, lysed and proteins were separated by SDS-PAGE.  Expression 
of iNOS (130 kDa) was visualized by western blotting using rabbit polyclonal anti-iNOS 
antibody. A low molecular weight non-specific band at 65 kDa was used as a loading 
control. A. Oxidative stress induced expression of iNOS in RPE cells. B. Light induced 
iNOS expression in RPE cells. Bands were quantified based on pixel size/intensity/area 
using Quantity One software (Bio-Rad). Graphs were plotted based on relative iNOS 
expression using GraphPad Prism software.  
3.4.3 Expression and localization of iNOS under oxidative stress 
We tested our hypothesis whether oxidative stress controls iNOS expression in RPE cells 
by using immunocytochemical analysis. Our fluorescent images show that iNOS 
expression increased under oxidative stress (200 μM, t-BuOOH) compared to untreated 
control as shown in figure 3.3A. A negative control without anti-iNOS primary antibody 
confirmed that our immunocytochemical images are iNOS-specific (Figure 3.3B). 
Nucleus staining with DAPI revealed cytoplasmic localization of iNOS.   
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3.4.4 Oxidative stress induced protein nitration shown by 3-nitrotyrosine in the RPE 
Formation of 3-nitrotyrosine is a post-translational modification caused by NO derived 
peroxynitirite during pathophysiological conditions, which in turn alters protein structure 
and function.  Our Western blotting analysis showed that relative protein nitration 
increased in 30, 35, 37 kDa proteins and other proteins (55, 32, 20, 18, 10 kDa) under 
oxidative stress (Figure 3.4 A).  Reduction (3-nitro tyrosine to 3-amino tyrosine) with 
disodium dithionite (Na2S2O4) confirmed the increased protein nitration in LPS, light and 






Figure 3.3A Increased expression of inducible nitric oxide synthase (iNOS) under 
oxidative stress.  ARPE-19 cells treated with tert-butyl hydroperoxide (200 μM for 36 or 
48 hrs.) were analyzed by immunocytochemistry. Expression of iNOS is visualized by 
the iNOS specific primary antibody, the Alexa Fluor 488-conjugated secondary antibody 
(green, iNOS) and DAPI (blue, nucleus) staining. Expression of iNOS was observed 





Figure 3.3B Negative control of iNOS immunocytochemistry. iNOS expression in RPE 
cells was confirmed by immunocytochemistry with Alexa-488 secondary antibody and 
without anti-iNOS antibody as a negative control. Absence of green fluorescence 
demonstrates that there are no non-specific binding proteins with Alexa-488 secondary 
antibody. DAPI (blue) represents counter staining for the nucleus. Scale bars represent 20 
μm.          
 
Figure 3.4 A Increased protein nitration in RPE under oxidative stress.  ARPE-19 cells 
were treated with tert-butyl hydroperoxide (200 μM for 36 h). Cells were harvested, lysed 
and proteins were separated by SDS-PAGE. A. Proteins with 3-nitrotyrosine were 
visualized by Western blotting using anti-3-nitro tyrosine antibody (1:50 dilution). 
Expression levels of nitrated proteins increased 2-3 folds under oxidative stress compared 
to untreated control. Protein loading was controlled by probing with anti-β actin 
antibody.  B. Bands represent the expression of nitrated proteins quantified by pixel 
intensity and area using Quantity One software (Bio-Rad). Quantitative analysis shows 2-
3 fold increased expression of nitrated proteins under oxidative stress compared to the 




Figure 3.4 C. Western blot analysis before and after reduction of nitrotyrosine to 
aminotyrosine. Nitration reduction (NO2 to NH2) was performed to confirm protein 
nitration, using disodium dithionite (Na2S2O4) to reduce 3-nitrotyrosine to 3-
aminotyrosine. Reduced tyrosine (3-aminotyrosine) showed no band on Western blotting 
using3-nitrotyrosine antibody compared to control (3-nitrotyrosine). ARPE-19 cell lysate 
from LPS, oxidative stress, and light treatment were separated by SDS-PAGE, and 
proteins were visualized by Western blotting. PVDF membrane was chemically reduced 
by 10 mM sodium dithionite (+ Na2S2O4 ) in 50 mM pyridine acetate buffer (pH 5.0) for 
1 hr before probing by anti-nitrotyrosine antibody. Another PVDF membrane was 
directly probed with anti-nitrotyrosine antibody without reduction (-Na2S2O4). 
3.4.5 NO Induced Vimentin Dephosphorylation and PP2Ac Phosphorylation in the 
RPE under Oxidative Stress 
Oxidative stress disrupts RPE cell junction and barrier integrity which may cause the 
pathogenesis of RPE related diseases through the degeneration of the blood-retinal barrier 
(Bailey et al., 2004). Increased site-specific phosphorylation of vimentin induces 
disassembly of vimentin intermediate filaments in vitro. Both cAMP dependent protein 
kinase and protein kinase C dependent phosphorylation of Ser-38 residue, which is 
located close to arginine substrate, were reported (Ando et al., 1989). To determine NO-
dependent cytoskeletal change that is regulated by PP2A phosphorylation signaling, we 
examined the interconnection of NO-vimentin-PP2A signaling (Figure 3.5).  Cells were 
treated with or without oxidative stress, L-arginine, and a NOS antagonist (N'1-nitro-L-
arginine methyl ester, L-NAME).  Cells treated with oxidative stress showed down-
regulation of the anti-apoptotic protein p-PP2Ac relative to the control group.  Bcl-xL is 
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also an anti-apoptotic protein and is down-regulated in all samples that are exposed to 
oxidative stress.  Bcl-xL expression increased in cells treated with L-arginine (2 mM) 
under oxidative stress. However, cells treated with oxidative stress, arginine, and L-
NAME together at the same time had lowest expression of Bcl-xL. Our data implies that 
increased levels of NO by L-arginine may have a protective role towards RPE cells under 
oxidative stress by inducing anti-apoptotic molecules, including Bcl-xL. Vimentin 
phosphorylation is up-regulated in cells under stress.  Cells treated with L-arginine (2 
mM) down-regulated vimentin phosphorylation whereas L-NAME along with L-arginine 
up-regulated vimentin phosphorylation under oxidative stress.  This is likely a result of 
increased cytoskeletal restructuring due to changes of intermediate filaments.  We then 
asked whether NO can induce PP2Ac catalytic subunit phosphorylation in the RPE under 
oxidative stress.  
 
Figure 3.5A. NO dependent concentration changes of p-Vimentin (Ser38), p-PP2Ac 
(Tyr307) and Bcl-xL under oxidative stress. ARPE-19 cells were incubated with tert-
Butyl hydroperoxide (200 μM) or L-Arginine (2 mM) or L-NAME (2 mM) for 24 hrs in 
serum free media. Cells were harvested, lysed in RIPA lysis to extract proteins.  Proteins 
were separated by SDS-PAGE and probed with anti- p-vimentin (Ser38), anti- p-PP2Ac 




Figure 3.5B Quantitative analysis of Figure 3.5A. Y axis represents relative 
phosphorylations in arbitrary unit (a.u.). X axis represents lanes. Lane 1. Control cells 
without treatments; Lane 2. Cells treated with 200 μM tert-butyl hydroperoxide only 
(oxidative stress); Lane 3. Cells treated with 200 μM tert-butyl hydroperoxide and 2 mM 
L-Arginine; Lane 4. Cells treated with 200 μM tert-butyl hydroperoxide and 2 mM L- 
NAME; Lane 5. Cells treated with 200 μM tert-butyl hydroperoxide, 2 mM L-Arginine 
and 2 mM L- NAME. 
Stimulation of endothelial cells with LPS and IFNγ increases NO-derived peroxynitrite. 
Up-regulation of peroxynitrite induces PP2Ac tyrosine nitration and nitrated PP2Ac 
inhibits PP2Ac phosphorylation. Activation of PP2A by nitration in turn causes 
endothelial barrier dysfunction (Bailey et al., 2004). We tested whether phosphorylation 
of PP2Ac is down-regulated under oxidative stress in RPE cells. Arginine treatment 
under oxidative stress shows up-regulated PP2Ac phosphorylation compared to oxidative 
stress only condition. Arginine treatment with or without L-NAME under oxidative stress 
clearly demonstrated that PP2Ac phosphorylation is down-regulated compared to non-
stress control.  
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3.4.6 NO Induced anti-Apoptotic Signaling in the RPE under Oxidative Stress. 
Anti-apoptotic protein Bcl-xL plays a significant role in RPE cell survival under normal 
and oxidative stress conditions. Reduced Bcl-xL expression levels confer apoptotic cell 
death in the RPE (Bailey et al., 2004). Inhibition of Bcl-xL expression alters RPE 
morphology and diminishes cell survival (Bailey et al., 2004) . We examined whether NO 
regulates anti-apoptotic signaling via Bcl-xL. While arginine addition increased Bcl-xL, 
NO reduction by L-NAME down-regulates Bcl-xL compared to oxidative stress only. 
This result suggests that vimentin phosphorylation may regulate apoptotic cell death 
signaling in RPE cells. Moreover, increased NO may play a protective role by enhancing 
anti-apoptotic signaling in the RPE under oxidative stress. Our data shows that Bcl-xL 
expression levels decreased in the RPE under oxidative stress. RPE cells treated with 
arginine shows increased expression of Bcl-xL under oxidative stress. 
3.4.7 Light induced vimentin filament disorganization in the RPE 
Interactions between microfilaments, intermediate filaments, and microtubules, stabilize 
structural, cytoskeletal organization of RPE cells. Vimentin is a major intermediate 
filament, which is responsible for cell adhesion, migration and signaling (Owaribe et al., 
1986). To investigate whether light stress may induce morphological changes through 
vimentin, we performed immunostaining with fluorescently labeled antibodies as shown 
in figure 3.6. Control cells in the dark show that vimentin filaments are extended 
throughout cytoplasm. Nuclear morphology appears as oval shaped and is intact. Intense 
light induced dramatic morphological changes as rounded vimentin filaments rather than 
extended form. Nuclear size decreased; major radius reduced to 60-50% and minor radius 
diminished 80-70% in length under intense light at 20 hrs compared to control. A patchy 




Figure 3.6 Vimentin filament changes in the RPE under light induced stress. ARPE-19 
cells were exposed to bright intense light (7000 Lux) for different time points (16 hrs and 
20 hrs). Cells were fixed in methanol at -20 ℃. Vimentin was probed by anti-vimentin 
and anti-goat Alexa 488 secondary antibody (green, vimentin filaments) and DAPI 
counterstaining (blue, nucleus).  Scale bars represent 20 μm. 
3.4.8 Apoptosis Mediated Morphological Changes of RPE under Oxidative Stress 
Morphological changes of the RPE are associated with various pathological conditions 
involved in many posterial ocular diseases. Our scanning electron microscopy analysis of 
RPE cells under oxidative stress demonstrates that the lateral, basal and apical cell 
surfaces of RPE are changed during apoptosis.  RPE cells were treated with 100 μM of 
H2O2 for 2 hrs. RPE cells under stress show that apoptotic cell surface changes by 
forming protrusion (Figure 3.7B), developing bubble-like blebs on their surface (Figure 
3.7C), phagocytic alteration like membrane disruption (Figure 3.7D) apical, basal and 
lateral surface changes, including dense projection of microvilli (Figure 7EF), broken 
into small, membrane-wrapped fragments (Figure 3.7GH). These results demonstrate that 
morphological changes of RPE cells under oxidative stress may lead to cell lysis, 




Figure 3.7 Cytoskeletal changes of RPE cells under oxidative stress were identified using 
scanning electron microscope (SEM).  ARPE-19 cells were treated with H2O2 (100 μM 
for 2 hrs). After fixation with 3% paraformaldehyde and 0.1% glutaraldehyde in 
phosphate buffer, morphological changes of ARPE-19 cells were observed  using JEOL 
JSM-6400 SEM at 4000 X magnification. A. Control, B-H. Sequential morphological 
changes of ARPE-19 cells under oxidative stress. Scale bar represent 8 µm.  
3.5 Discussion 
Oxidative stress-induced apoptosis is the final cell death pathway in many irreversible 
ocular diseases (Chang et al., 1993; Porteracailliau et al., 1994). While the end point of 
apoptosis is well established, the knowledge of early biochemical reactions and 
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molecules has been elusive. We have examined early biosignatures and mechanisms of 
retinal and RPE cell death under oxidative stress (Arnouk et al., 2011b; Chung et al., 
2009b; Lee et al., 2010c; Lee et al., 2011; Sripathi et al., 2011c; Zhang et al., 2010b). Our 
previous studies demonstrated that not only intense light but also constant moderate light 
and mild oxidative stress may trigger induction of anti-apoptotic Bcl-xL and 
erythropoietin as well as pro-apoptotic caspases. NO is generated from the oxidation of 
the guanido nitrogen of its substrate L-arginine with the stoichiometric formation of L-
citrulline by nitric oxide synthase in the presence of oxygen and NADPH. Enzymatic NO 
formation is involved in physiological processes, including the control of vascular tone, 
inhibition of platelet aggregation, smooth muscle cell replication, immune response, and 
wound healing processes (Mann and Motterlini, 2007). NO has been recognized for its 
paradoxical role as a promoter of cell growth (vascular neogenesis) and cell death 
apoptosis (Mocellin et al., 2007; Rose and Mascharak, 2008). Exposure to intense light 
may induce protein nitration via iNOS activation in the retina, which in turn mediates 
photoreceptor cell death (Palamalai et al., 2006). Elevated tyrosine nitration was observed 
in the inner segments of photoreceptors and RPE upon intense light exposure due to 
increase NO production (Miyagi et al., 2002). Inflammatory response and high oxygen 
demand in the retina are expected to increase NO generation and oxidative damage to 
Bruch’s membrane and could lead to pathophysiological protein nitration (Miyagi et al., 
2002). NOS is categorized into three isoforms such as calcium-dependent neuronal 
(nNOS), endothelial (eNOS) isoforms, and the inducible, calcium independent isoform 
(iNOS), which are related to neuronal communication, vasolidation and inflammation 
signaling, respectively (Knowles and Moncada, 1994; Marletta, 1993). Optimum 
expression levels of NOS isoforms are tightly regulated for normal retinal cell 
homeostasis and RPE phagocytosis. A high concentration of NO could lead to the 
accumulation of protein aggregates between photoreceptors and RPE cells, which results 
in photoreceptor degeneration (Knowles and Moncada, 1994). Light-induced oxygen 
radicals are mediators of retinal photic injury, based on the observation of the protective 
effect of free radical scavengers in the light damaged model (Knowles and Moncada, 
1994). However, decreased expression of eNOS and nNOS were also observed in 
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neuronal and vasoconstrictive changes in AMD choroid. Changes of NOS in AMD 
suggest that retinal degeneration is directly or indirectly related to local NO concentration 
in the RPE. NO reacts with superoxide anion (O2.-) to produce peroxynitrite (ONOO-), a 
potential cytotoxic and tyrosine nitrating molecule under oxidative stress (Knowles and 
Moncada, 1994). Peroxynitrite modulates tyrosin phosphorylation and dephosphorylation 
during postsynaptic compartments during cell regulation (Di Stasi et al., 1999). 
Exogenous NO exposure also resulted in cytoskeletal reorganization through 
phosphorylation of VASP (vasodilator-stimulated phosphoprotein) in diabetes model 
(Calzi et al., 2008). The current study suggests that NO may regulate phosphorylation of 
PP2Ac and vimentin as a physiological regulator of cell respiration to become an agent of 
cell pathology. In addition, the excessive level of NO or the deficiency of NO may 
control endothelial dysfunction under oxidative stress. Our results demonstrate that 
oxidative stress induced disassembly of vimentin intermediate filaments may cause 
vimentin phosphorylation in the RPE. L-Arginine uptake by RPE cells significantly 
increases the NO levels in diabetic rat RPE (Calzi et al., 2008). The current study implies 
dual roles of NO with 1-10 nmole of NO may protect RPE cell by PP2A and vimentin 
phosphorylation, whereas higher NO (>100 nmole) generation under oxidative stress may 
induce apoptosis. Our results show that arginine treatment under oxidative stress 
significantly decreases vimentin phosphorylation compared to no arginine treatment 
under oxidative stress. Treatment of NOS antagonist, N'1-nitro-L-arginine methyl ester 
(L-NAME) along with arginine under oxidative stress, shows that vimentin 
phosphorylation increased compared to arginine only. Addition of both arginine and L-
NAME under oxidative stress reveals that vimentin phosphorylation has positive and 
negative correlations with NO under oxidative stress. 
 Based on our observations in the current study, we postulate that light may induce post-
translational modifications of target proteins, including vimentin and PP2Ac. We 
speculate that PP2Ac phosphorylation may control its subunit binding that determines its 
phosphatase activity and substrate specificity under stress conditions. A stabilized 
vimentin may act as an anti-apoptotic agent when cells are under stress. Our previous 
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results demonstrated that PP2A and vimentin are modulated by constant light, and are 
key elements involved in cytoskeletal signaling in rd1 mutation model (Zhang et al., 
2010b). A positive correlation between the levels of PP2A and vimentin under light-
induced stress suggests that cytoskeletal dynamics are regulated by phosphorylation of 
vimentin.  
PP2A is a heterotrimeric serine/threonine phosphatase, which ubiquitously performs 
dephosphorylation reactions in cell signaling cascades, including Raf, MEK, and AKT.  
The regulatory subunit PP2Ab enhances the formation of stable complexes between 
PP2Aa-c. PP2A positively regulates apoptosis by controlling pro-apoptotic (Bad, Bak, 
Bax) and anti-apoptotic (Bcl-xL) Bcl-2 family members (Medearis et al., 2011). PP2A 
dephosphorylates phosducin, a phosphoprotein which modulates the light activated 
phototransduction cascade in vertebrate retina (Wu and Wilson, 2009). Suppression of 
endogenous PP2Aa by 50% leads to cell transformation; further suppression results in 
cell cycle arrest and apoptosis. This suggests that the suppression of PP2A a or c levels 
induce apoptosis and that a minimal level of PP2A a or c is required for cell survival 
(Chen et al., 2005). Under light condition, efficient dephosphorylation of phosducin by 
PP2A is required to quench high sensitivity so that more intense light can be sensed. 
PP2Ac tyrosine residue undergoes nitration by peroxynitrite that correlates with 
decreased tyrosine phosphorylation and increased dephosphorylation activity (Monteiro 
et al., 2008). Although the potential importance of protein dephosphorylation as a 
therapeutic target has been appreciated, no detailed approach to date has been made that 
targets PP2A, especially on retinal degeneration (Kalev and Sablina, 2011; Tanimukai et 
al., 2009). Abnormalities in PP2A activity and concentration have been linked to 
neurodegenerative diseases, including Alzheimer’s and Parkinson’s. However, the 
mechanism by which PP2A activity is regulated under oxidative stress remains largely 
elusive. Recent advances in the structural investigation and the light-driven switch 
mechanism have elucidated PP2A-induced dephosphorylation signaling in the retina 
(Brown et al., 2002; Cho and Xu, 2007; Xu et al., 2006). Modulating light-induced post-
translational modifications of PP2A and vimentin through NO signaling may assist in 
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maintaining the proper filament network in Müller cells, which subsequently supports 
cell survival and architecture in the retina and RPE.  
Our results demonstrate that NO concentration and duration may influence cytoskeletal 
dynamics and apoptotic pathway via phosphorylation signaling under stress conditions. 
As progressive loss of neuronal structure precedes cell death, our data elucidates the 
regulatory mechanism of cytoskeletal organization governed by NO and PP2A/vimentin 
phosphorylation. These outcomes are expected to have an important positive impact, 
because modulation of NO might be assigned as a therapeutic intervention to serve as the 
pathological target for the balanced phosphorylated cytoskeleton (Thomas et al., 2004; 
Thomas et al., 2008). 
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Oxidative stress contributes towards the disruption of mitochondrial structural integrity, 
cytoskeletal reorganization and differential expression of pro or anti apoptotic proteins 
and further leads to progressive cell death of retina and RPE. Our previous study 
demonstrates that prohibitin levels are upregulated in the retina but downregulated in the 
RPE of aging and diabetic model.  Differential expression of prohibitin and the 
identification of interacting proteins in the retina and retinal pigment epithelium (RPE) 
may provide insights into apoptotic signaling mechanism during the progression of 
retinal degenerative diseases such as age-related macular degeneration (AMD) and 
diabetic retinopathy (DR). In this study differential expression of prohibitin and its 
regulation is studied using proteomic strategies including western blotting, 
immunoprecipitation, two-dimensional electrophoresis and MALDI-TOF mass 
spectrometry. Our western blotting analysis reveals that prohibitin levels are decreased in 
the retinas of diabetic retinopathy but the levels are significantly elevated in the aged 
retinas from mouse, rat models and human donor eyes. Prohibitin levels in the central and 
peripheral retina are increased but the levels are decreased in the central and peripheral 
RPE of human AMD eyes. Our mass spectrometry analysis reveals that prohibitin might 
interact with phospholipid binding receptors, mitochondrial structure determinant 
proteins and anti-apoptotic regulatory proteins. In the present study we propose that 
prohibitin levels in the retina and RPE determines the mitochondrial stability, function 
and apoptotic signaling during the progression of age-related macular degeneration 
(AMD) and diabetic retinopathy (DR).  
4.2 INTRODUCTION 
Mitochondrial dysfunction that includes oxidative damage and altered energy levels leads 
to accelerated aging and age-related diseases. Age-related macular degeneration (AMD) 
involves progressive cell death of post-mitotic retinal pigment epithelial (RPE) cells, 
which then adversely affects rod and cone survival. AMD is characterized in its early 
stages by the presence of extracellular deposits, known as drusen, that accumulates 
between the basal surface of the RPE and Bruch’s membrane. Oxidative stress and 
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uncontrolled activation of the alternative complement pathways, especially at the 
membrane surface of RPE cells, are thought to be independently associated with AMD. 
Emerging evidence suggests that development and progression of AMD involves 
significant alteration in cell signaling proteins especially apoptosis and immune 
signaling. However, the identity of the molecules responsible for triggering activation of 
RPE apoptosis, as well as the downstream molecular interactions that promote AMD 
pathology, remain elusive. We have been actively seeking early molecular signaling 
events under oxidative stress in the retina and RPE using a proteomics and metabolomics 
approach to identify new biomarkers of retinal degeneration (Arnouk et al., 2011b; 
Chung et al., 2009a; Jahng, 2012; Lee et al., 2010a; Lee et al., 2010b; Lee et al., 2011; 
Sripathi et al., 2012; Sripathi et al., 2011c; Zhang et al., 2010b). This approach 
demonstrated that prohibitin is involved in oxidative stress signaling in vitro and in vivo. 
Prohibitin was originally identified as an anti-proliferative protein (McClung et al., 
1995a) that is highly conserved from bacteria to human suggesting essential cellular 
survival function (Nuell et al., 1991). However, the molecular mechanism of prohibitin 
on aging and lipid metabolism is not clearly understood. For the last twenty years, 
prohibitin has been proposed to have a role as a cell cycle inhibitor (Mcclung et al., 
1995b), a transcriptional regulator (Fusaro et al., 2003b; Wang et al., 2002a), an 
inflammatory modulator (Sharma and Qadri, 2004b; Theiss et al., 2007a), a plasma 
membrane receptor (Kolonin et al., 2004b), a mitochondrial chaperone (Nijtmans et al., 
2000b; Sanz et al., 2004) and a lipid binding shuttle (Sripathi et al., 2011b). Prohibitin is 
involved in apoptosis and aging by stabilizing newly synthesized respiratory enzymes, 
however, its presence and function in the eye has been elusive. Localization of prohibitin 
has been controversial, being mitochondrial, nuclear, or cell surface, possibly due to 
different cell type and lipid membrane environment. Our previous biochemical 
experiments demonstrated that prohibitin is a lipid binding shuttle primarily expressed in 
mitochondria, however, it translocalizes to the nucleus under stress condition. The extent 
of prohibitin localization in mitochondria inversely correlates with levels of oxidative 
stress. Knockdown approach using siRNA suggests that prohibitin may have the anti-
apoptotic function through Bcl-2 and mitochondrial DNA binding mechanisms. Our data 
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further suggests that specific lipid-binding mechanisms involving altered cardiolipin 
interactions might be the key element to determine prohibitin shuttling between 
mitochondria and the nucleus. Mitochondrial dysfunction is associated with AMD and 
our studies also suggest specific patho-physiological mechanisms involving altered 
mitochondrial disruption. The current in vivo models and molecular interaction studies, 
inlcuding lipid, nucleotide and protein with prohibitin, may provide a new insight into the 
underlying mechanisms involved in the development and progression of AMD and 
further suggest the relationship between various risk facotors, such as oxidative stress and 
aging. Such information are critical for the development of more effective therapeutic 
strategies for the treatment of AMD.  
4.3 MATERIALS AND METHODS 
4.3.1 ARPE-19 and HRP Cell Culture  
Human retinal progenitor (HRP) cells and human retinal pigment epithelial (ARPE-19) 
cells were obtained from University of North Texas Health Science Center and ATCC 
(Manassas, VA) respectively. Cells were cultured in  56.7 cm2 dishes  (Nunc,  Naperville, 
IL) containing Dulbecco’s modified Eagle's medium (DMEM) supplemented with 10% 
fetal bovine serum (FBS) and 1% penicillin/ streptomycin and the flasks placed in a 5% 
CO2 incubator at 37 °C.  Confluent cells were retrypsinized with a 0.1%trypsin-EDTA 
(Sigma, St. Louis, MO) for 5-7 min at 37 °C. After centrifugation (125g for 7 min), cells 
were plated in fresh culture dishes and allowed to grow to confluence for 2−4 days. 
Eight- to nine -passage cells were used for oxidative stress treatment.  
4.3.2 Oxidative Stress Treatment 
To induce oxidative stress in vitro confluent HRP and ARPE-19 cells were incubated 
with 200 μM of tert-butyl hydroperoxide (Sigma, St. Louis, MO) in serum free medium 
for 1 hr and 2 hrs respectively. Cells were washed twice with PBS before being 
harvested. Cells were lysed using mild detergent based lysis buffer to perform co-
immunoprecipitation with prohibitin antibody.  
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4.3.3 Treatment of Animals 
Adult male Sprague-Dawley (SD) rats (250-300g) and mice (C57 black) obtained from 
Charles River Laboratories (Wilmington, MA) were made diabetic by intravenous 
injection with streptozotocin (STZ) (Sigma, St. Louis, MO) (65mg/kg dissolved in 0.1M 
sodium citrate [pH 4.5].  Control rats and mice were delivered injections of vehicle 
alone.  Rats and mice were considered to be diabetic at blood levels >350 
mg/dL.  Animals were sacrificed 2 and 4 weeks following onset of diabetes by an 
overdose of anesthesia. Comparative analysis was conducted with an identical animals 
strain (SD). Control SD rats and mice were sacrificed at 12 weeks of age and aged SD 
rats and mice were sacrificed at 52 and 54 weeks of age. Retinas of SD rats and mice 
were removed and snap frozen in liquid nitrogen. Retinas from different subgroups were 
collected and were prepared for biochemical analysis. 
4.3.4 Donor Eye Tissues 
Human diabetic retinopathy (DR), aged and control retinal tissue was obtained from 
Georgia eye bank.  Human age-related macular degeneration (AMD) retinal (8mm 
macular and peripheral) and RPE (8mm macular and peripheral) and age matched control 
eye tissue was provided by the Lions eye bank at University of Utah, UT. 
4.3.5 Co-Immunoprecipitation 
HRP and   ARPE-19 cells were washed once with 1X Modified Dulbecco’s PBS and lyse 
the cells by adding ice cold IP lysis buffer [25 mM Tris, 150 mM NaCl, 1mM EDTA, 1% 
NP-40, 5% glycerol; pH 7.4 and protease inhibitor cocktail] by incubating on ice for 5 
min and periodic sonication (3 × 5 min) followed by centrifugation at 13,000 × g for 10 
minutes to pellet the cell debris. Proteins in the supernatant were pre cleared using 
control agarose resin, cross-linked by 4% bead agarose, to avoid the nonspecific binding. 
The anti-prohibitin antibody immobilization is performed using amino-linked protein- A 
beads by coupling buffer [1 mM sodium phosphate, 150 mM NaCl (pH 7.2)] followed by 
incubation with 3 μL of 5 M sodium cyanoborohydride solution on rocker at RT for 2 hrs 
to make the slurry suspended. Columns were briefly washed with a wash solution [1M 
NaCl] and protein lysate was incubated in the protein A-antibody column with gentle 
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rocking for overnight at 4 °C. Spun down the unbounded proteins as flow through and the 
columns were washed thrice with wash buffer to remove nonspecific binding proteins. 
Elute the interacting proteins by incubating with elution buffer for 5 min at RT. Finally 
the eluted proteins were equilibrated with 5X Laemmli sample buffer with the final 
concentration of 10% β- mercaptoethanol.  Eluted proteins were resolved on SDS−PAGE 
and interacting protein bands were visualized by either coomassie (Pierce, IL) or silver 
staining (Bio-Rad, Hercules, CA). 
4.3.6 In-Gel Digestion and MALDI TOF Mass Spectrometry  
 Selected protein bands from gels were excised into cubes (ca. 1×1 mm). The coomassie 
stained gel pieces were destained twice with 200 μL of 50% acetonitrile (MeCN)/25 mM 
NH4HCO3 buffer (pH 8.0) at room temperature for 20 min, whereas the silver stained gels 
pieces were destained by soaking in 1:1 mixture of 30 mM potassium ferricyanide and 
100 mM sodium thiosulfate for 5 min until the silver stain disappears and washed the gel 
pieces thrice with water.  Incubate the gel pieces once with 200 μL of 100% MeCN until 
they become white and shrink, and vacuum-dried with a Speed Vac concentrator (Savant, 
Holbrook, NY).  Reduce the proteins with 10 mM DTT in 100 mM NH4HCO3 for 30 min 
at 56 ºC in an air thermostat and alkylate with 55 mM iodoacetamide in 100 mM 
NH4HCO3 for 20 min at RT in dark. The gel pieces were saturated with 13 ng/μL 
sequencing grade modified trypsin (Promega, Madison, WI) in 10 mM NH4HCO3 
containing 10 % (vol/vol) MeCN  and incubated the samples  in air circulation thermostat 
at 37 °C for overnight.  Subsequently, the peptides were enriched twice with 50 μL of a 
50% MeCN/5% formic acid mixture for 20 min at 37 °C in a shaker. The solution 
containing peptide mixture is completely vacuum dried. The dried peptide is dissolved in 
5-10 μL of 75% MeCN/1% TFA solution. The matrix α-cyano-4-hydroxycinnamic acid 
(5 mg/mL CHCA, MW 189.04 Da) (Sigma, St. Louis, MO) is freshly dissolved in 50 % 
acetonitrile/1% triflouroacetic acid (TFA) and centrifuged at 13,000 g for 5min. The clear 
matrix solution is mixed with the tryptic digested peptide and spotted the 0.5 μL of the 
matrix/peptide mixture on to the MALDI target (Ground steel, Bruker Daltonics, 
Germany) and allowed to form dried droplet of the sample. Commercially available 
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target with pre-spotted known peptide samples were used to calibrate the accuracy of 
instrument. The mass spectra range of 800-3000 Da with the laser intensity of 70-75% 
and 100-300 shot numbers, was measured using Flex control MALDI-TOF mass 
spectrometry (Bruker Daltonics, Germany). Internal calibration for all the mass spectra 
were performed based on the autolysed trypsin (Promege) products (m/z 842.509 and 
2211.105). Data analysis was performed using Flex analysis software (Bruker). Protein 
database is performed using Mascot search engine software (Matrix Science) along with 
the NCBI/SwissProt database(s) and followed the different parameters such as Taxonomy 
- Homo sapiens; allowed zero mismatch cleavage with fixed carbamidomethyl (C) 
modification of cysteine and variable modification of methionine oxidation. 100-300 ppm 
was considered as peptide mass tolerance.  Peptide identification is considered based on 
the MASCOT Mowse scores, number of matched peptides and protein sequence 
coverage.  
4.3.7 Immunocytochemistry  
ARPE-19 cells were cultured on sterile glass cover slips with DMEM/F12 medium 
supplemented with 10% FBS and 1% penicillin–streptomycin (Hyclone) in 5% CO2 
incubator at 37 °C. Cells were treated with 200 μM of hydrogen peroxide for 2 hrs to 
induce oxidative stress.  Cells were briefly washed with PBS and incubated with the final 
concentration 100 nM MitoTracker Orange CMTMRos (Molecular Probes, Carlsbad, 
CA) in serum free culture medium for 30 min at 37 °C. Cells were washed with PBS and 
fixed with 10% formaldehyde for 30 min at RT. After fixation, cells were treated  in 
0.2% Triton X-100 (Sigma) in PBS for 30 min to permeabilize the  cell membrane and 
the cells were blocked with complete medium containing 10% FBS and 0.05% Tween-20 
(Sigma) for 1 hr. Cells were probed with anti-prohibitin antibody (1:1000; Genemed 
Synthesis Inc, San Antonio, TX) for overnight at 4 °C. Cells were washed with PBS and 
incubated with Alexa Fluor 488-conjugated anti-rabbit IgG secondary antibody (1:700; 
Molecular Probes) for 1 h at RT.  To counter stain the nucleus, cells were mounted with 
VECTASHIELD mounting medium containing DAPI (4,6-diamidino-2-phenylindole).  
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Images were acquired on fluorescent microscope (Zeiss AxioVert 200 M Apo Tome) 
with 63× magnification. Images were analyzed and merged using ImageJ software (NIH).  
4.3.8 SDS−PAGE and Western Blot Analysis 
Protein quantification was performed using BCA protein assay kit (Pierce) by plotting 
BSA standard curve graph. Protein samples were dissolved in 5X Laemmli sample buffer 
(240 mM Tris pH 6.8, 8% SDS, 40% glycerol, 0.4% bromophenol blue, 10% β- 
mercaptoethanol) followed by denaturation at 90°C for 10 min. Proteins were resolved 
using 8-16% gradient polyacrylamide precast gels (Bio-Rad), followed by electrotransfer 
on to the methanol activated PVDF membrane (Bio-Rad) using semidry transfer by 
applying 15V for 30 min. Non-specific proteins were blocked with 5% nonfat dry milk 
(Bio-Rad) prepared in TBS with 0.1 % (v/v) Tween-20 for 2 hr at 4°C. Membranes were 
probed with primary antibody prohibitin (Rabbit polyclonal, 1:1000; Genemed Synthesis 
Inc. TX) at 4 °C for overnight on a shaker. Subsequently, the membrane is incubated with 
anti-rabbit HRP conjugated secondary antibody (1:10000; Agrisera, Vännäs, Sweden) for 
2 h at room temperature on shaker. Antibody probed membranes were developed with 
West Pico Chemiluminescent Substrate (Pierce) for 1-2 min. The immunoreactive protein 
bands (signal) were visualized by LAS 4000 mini luminescent image analyzer (GE, 
Piscataway, NJ).  Membranes were reprobed with the β-actin (mouse monoclonal, 
1:5000; Sigma, St. Louis, MO) followed by the incubation with anti-mouse HRP 
conjugated  secondary antibody (1:7,000; Santa Cruz Biotechnology Inc, CA) for loading 
control. All the immunoblots were performed in triplicate.  Bands were quantified based 
on pixel size/intensity/area using Quantity One software (Bio-Rad) and graphs were 
plotted based on relative intensity of bands using GraphPad Prism software. 
4.4 RESULTS 
4.4.1 Prohibitin Expression Downregulated in the Retina of the Diabetic Model 
Prohibitin regulates lipid metabolism by binding specific phospholipids, including 
cardiolipin and PIP3 (Sripathi et al., 2011c). Increased prohibitin levels negatively affect 
insulin signaling through tyrosine phosphorylation as phosphatidylinositol-3 kinase 
(PI3K) downstream (Ande and Mishra, 2009). We tested our hypothesis that prohibitin 
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signaling could be altered in diabetic pathway or aging model. We examined whether 
mitochondrial prohibitin was altered during hyperglycemic condition using streptozotocin 
(STZ)-treated murine or diabetic human model. Our Western blotting analysis showed 
that the prohibitin levels decreased significantly in the diabetic retina from the STZ-
induced mouse and rat (Figure 4.1-3). Next, considering reactive oxygen species (ROS) 
accumulation leads to the disruption of mitochondrial network during aging, we tested 
our hypothesis that prohibitin expression could be changed in aged retinas from mouse, 
rat (12 months), and human (71 years) compared to controls. In contrast to diabetic 
condition, we observed that the level of prohibitin is significantly increased in rats and 
humans, whereas minimum changes in elevated expression in the mouse retina (Figure 
4.1-3). 
 
Figure 4.1 Expression difference of mouse retinal prohibitin (PHB) in control, diabetic 
retinopathy (DR) and aged retina was analyzed by western blotting. Retinal tissue from 
was homogenized in RIPA buffer followed by sonication. Proteins were separated by 
SDS-PAGE and PHB expression was visualized by western blotting. β-actin blot was 
used as a loading control. Bands were quantified based on pixel size/intensity/area using 
Quantity One software (Bio-Rad). Graphs were plotted based on relative prohibitin 




Figure 4.2 Expression difference of rat retinal prohibitin (PHB) in control, diabetic 
retinopathy (DR) and aged retina was analyzed by western blotting.  
 
Figure 4.3 Expression difference of human retinal prohibitin (PHB) in control, diabetic 
retinopathy (DR) and aged was analyzed by western blotting.  
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4.4.2 Prohibitin Expression Increased in the Retina but Decreased in the RPE of 
AMD 
The increased levels of reactive oxygen species under oxidative environment may initiate 
various pathophysiological events in the retina and RPE. Differences in region-specific 
protein content were reported in central and peripheral retina in the progression of AMD 
(Lee et al., 2010c). Since the susceptibility towards oxidative stress significantly varies 
from the retina and RPE cells, we aimed to analyze prohibitin expression in the macular 
and peripheral retinal and RPE region. Our Western blot analysis demonstrates that the 
prohibitin levels increased significantly in both macular (8 mm) and peripheral retinal 
region from the postmortem donor eyes of AMD (Figure 4.4). However, prohibitin levels 
decreased dramatically in both macular RPE region and peripheral RPE in AMD eyes 
compared to age matching controls, suggesting mitochondrial dysfunction and RPE cell 
death in AMD (Figure 4.5). β-tubulin expression was used as a loading control. 
 
Figure 4.4 Expression difference of prohibitin (PHB) in human Age-related Macular 
Degeneration (AMD) retina (8mm macular, peripheral retina) was analyzed by western 
blotting. Retinal tissue and RPE cells were homogenized in RIPA buffer followed by 
sonication. Proteins were separated by SDS-PAGE and PHB expression was visualized 
by western blotting. β-tubulin blot was used as a loading control.  Bands were quantified 
based on pixel size/intensity/area using Quantity One software (Bio-Rad). Graphs were 





 Figure 4.5 Expression difference of prohibitin (PHB) in human Age-related Macular 
Degeneration (AMD) retinas (8mm macular, peripheral retina) were analyzed by western 
blotting. RPE cells were homogenized in RIPA buffer followed by sonication. Proteins 
were separated by SDS-PAGE and PHB expression was visualized by western blotting. 
β-tubulin blot was used as a loading control.  Bands were quantified based on pixel 
size/intensity/area using Quantity One software (Bio-Rad). Graphs were plotted based on 
relative prohibitin expression using GraphPad Prism software.   
4.4.3 Prohibitin Depletion in the RPE 
To examine prohibitin depletion phenotype as shown in the RPE of AMD eyes, we 
determined a loss of function study using prohibitin-targeting small interfering RNA 
(siRNA). Prohibitin knockdown experiment demonstrates that a decreased level of 
prohibitin disrupts the regular lamellar cristae whereas random sequence control and t=0 
control does not affect the structure of mitochondria. The mitochondrial morphology, 
visualized by MitoTracker, showed that prohibitin silencing led to mitochondrial 
fragmentation instead of the tubular shape as shown in control cells (Figure 4.7). Then we 
examined prohibitin expression and mitochondrial morphological differences in RPE 
under oxidative stress. Our immunocytochemical analysis of retinal pigment epithelial 
cells (ARPE-19) shows that the disrupted mitochondrial morphology under oxidative 
stress (200 µm H2O2) compared to the untreated control (Figure 4.7). However, we found 
no difference in the nuclear DNA morphological aberration between oxidative stress and 
control.  MitoTracker Orange (mitochondria, red, 578 and 599 mm for absorption and 
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emission), DAPI (nuclear DNA, blue, 369 nm absorption and 460 nm emission) and 
Alexa Fluor 488 (prohibitin, green, 495 nm absorption and 519 nm emission) were used 
to label subcellular organelles and prohibitin, respectively.  
 
Figure 4.6 Depleted levels of prohibitin are shown by siRNA knockdown analysis. 
ARPE-19 cells were transfected by prohibitin specific siRNA in serum free medium by 
time dependant manner (36 to 72 h).  Prohibitin expression and depleted levels were 
analyzed by Western blotting analysis form cell extracts. Prohibitin levels were 
diminished during siRNA knockdown analysis. β-actin expression levels were considered 
as a loading control.  
 
Figure 4.7 Mitochondrial morphological changes during prohibitin siRNA knockdown 
analysis.  ARPE 19 cells were treated with prohibitin specific siRNA (175 ng for 48 h) 
and random sequence control were analyzed by immunocytochemical analysis. 
Subcellular organelles and prohibitin levels were visualized by DAPI (blue, nucleus), 
MitoTracker Orange (red, mitochondria) and the prohibitin-specific primary antibody, the 
Alexa Fluor 488-conjugated secondary antibody (green, prohibitin).Disrupted 
mitochondrial morphological changes were observed under prohibitin depleted levels. 
The scale bar is 5 μm. 
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4.4.4 Prohibitin-Lipid Interaction 
We next asked whether prohibitin in various organelles or cells may have different 
cardiolipin affinity to test subcellular organelle-specific prohibitin-lipid interactions. 
Previously, the prohibitin-lipid binding assay demonstrated that prohibitin binds with 
cardiolipin, a major mitochondrial phospholipid, under oxidative stress (Sripathi et al., 
2011a). The lipid interaction assay demonstrates that microsomal and cytosolic prohibitin 
showed stronger interaction compared to mitochondrial and nuclear prohibitin (Figure 
4.8). In addition, prohibitin from bovine RPE or ARPE19 cells did not show any 
interaction with cardiolipin, however, prohibitin from the bovine retina showed 
cardiolipin binding. Microsomal prohibitin showed strong interaction with cholesterol 
and weaker interaction with phosphatidylserine. To determine cardiolipin and cholesterol 
changes under oxidative stress, relative lipid concentrations were analyzed by mass 
spectrometry. Cardiolipin decreased 20% under 200 µM H2O2 in a time and dose 
dependent manner (Figure 4.8) and cholesterol/cholesterol ester increased roughly 2.5 
fold (data not shown). Addition of cholesterol (125-250 µM) to APRE19 cells during cell 
culture down-regulated prohibitin and prohibitin2 expression (Figure 4.9). Addition of 
beta-cyclodextrin increased prohibitin expression (data not shown). Our data suggests 
that prohibitin from a different subcellular organelle or different cells may have a 
different affinity to cardiolipin. Further, our data may suggest that prohibitin expression 




Figure 4.8 Subcellular prohibitin-lipid binding analysis. Blotting hybridization with 
PHB-antibody shows that subcellular PHBs have different binding affinity with 
cardiolipin, cholesterol and phosphatidylserine. Retina PHB and cardiolipin have strong 
binding affinity, while bovine RPE and human RPE (ARPE-19) PHB have weak binding 
affinity. Retinal microsomal PHB binds have high binding affinity with cardiolipin, 
cholesterol, and phosphotidylserine. Microsomal fraction applied onto PVDF membrane 
is considered as a negative control. 
 
Figure 4.9 Quantitative analysis of Subcellular prohibitin-lipid binding:  Spots were 
quantified based on pixel size/intensity/area using Quantity One software (Bio-Rad). 
Graphs were plotted based on relative prohibitin expression using GraphPad Prism 
software.   
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 4.4.5 Prohibitin-Nucleotide Interaction 
To understand the origin of mitochondrial dysfunction by prohibitin depletion, we next 
asked the question of prohibitin-nucleotide interaction. Under oxidative stress, 
mitochondrial DNA (mtDNA) is more susceptible to damage than nuclear DNA 
(nuDNA) due to oxidative metabolism in mitochondria (Lee et al., 2010a). Thus, we 
examined whether prohibitin binds to mitochondrial or nuclear DNA to determine its 
molecular chaperone function. We tested the hypothesis that mitochondrial prohibitin 
may show different affinity toward mitochondrial DNA versus nuclear DNA. Using a 
native gel assay, we examined whether prohibitin in mitochondrial and nuclear extracts 
bind to mtDNA and nuDNA. It was found that mitochondrial prohibitin forms protein-
mtDNA complex at 720 kDa as shown in Figure 4.11 lane 2 and 3, whereas it forms 150 
kDa complexes with nuclear DNA. Nuclear prohibitin showed the weaker interaction 
with mitochondrial and nuclear DNA, forming mixtures of 720 and 150 kDa complexes 
(Figure 4.10, lane 5-8). Higher concentration of mtDNA and nuDNA with nuclear 
prohibitin breaks molecular interactions showing monomeric prohibitin at 32 kDa (Figure 
4.11, lane 6 and 8). To confirm prohibitin-mtDNA interaction, we used the sedimentation 
assay using mitochondrial prohibitin with or without mtDNA. Prohibitin from 








Figure 4.10 Cholesterol dependent prohibitin expression from RPE. ARPE-19 cells were 
treated with different concentrations of cholesterol for 16 hrs. Proteins were separated by 
SDS-PAGE and prohibitin expression is visualized by western blotting analysis. 
Increased cholesterol levels significantly down regulate the PHB1 expression whereas 
PHB2 levels show less sensitivity towards elevated cholesterol levels.  
 
Figure 4.11 Prohibitin-DNA binding analysis.  Sub cellular mitochondrial and nuclear 
PHB fractions from bovine retina were intercross mixed with gel-purified mitochondrial 
(mt) and nuclear (nu) DNA extracted from bovine retina. DNA-protein complexes were 





 Prohibitin-Binding Proteins  
To understand the downstream signaling of prohibitin in various subcellular organelles, 
prohibitin-binding proteins were determined using immunoprecipitation (IP) analysis. 
(Figure 4.12-13). ARPE-19 cells were treated with or without oxidative stress (200 mM, 
t-BuOOH) and 49 putative prohibitin binding proteins in elution fractions were analyzed 
by MALDI-TOF mass spectrometry. IP with preimmune serum and a blank gel with 
trypsin digestion were used as negative controls and prohibitin-p53 binding was 
considered as a positive control (data not shown). Identified protein name, accession 
number, probability MOWSE score, sequence coverage, predicted mass, predicted pI, 
and identified peptide number were presented. Among these, a couple of cytoskeletal 
proteins, including kinesin, actin and myosin head motor domain, were found in both 
control and oxidative stress. Actins are highly conserved proteins that are involved in cell 
motility and structural integrity. It has a nucleotide binding domain which is crucial in the 
proper function of ion channels. Nucleoporin-like protein at 86 kDa transports 
macromolecules between the  nucleus and cytoplasm. Nucleoporin and lamins are 
speculated to be involved in the translocation of prohibitin between the nucleus and 
mitochondria. PI3K, p85 binding domain, suggests that prohibitin is involved in PIP3 
pathway to regulate lipid and insulin signaling.  Nuclear mitotic apparatus protein 1 
isoform (NUMA) belongs to the same coiled coil family as prohibitin, myosins, lamins 
and intermediate filaments. NUMA is proposed to play a role in maintaining and 
establishing nuclear structure, possibly as a structural component of the nuclear matrix. 
Next, we used HRP (human retinal progenitor) cells to gain better understanding whether 
prohibitin in the retina may have similar function or binding partners. Actin and myosin 
binding of prohibitin may suggest mitochondrial DNA maintenance function of prohibitin 
in the retina. Pleckstrin (PH) domain containing protein, PH2, Rab21 binding implies 




Figure 4.12   Immunoprecipitation of PHB interacting proteins. Coomassie stained gel of 
immunoprecipitated proteins from control ARPE-19 cells (lysate) with anti-PHB 
antibody. Cells were harvested, lysed followed by Co-IP and separated by SDS-PAGE. 
Proteins in the W1 to W3 represents wash fractions; E1 to E3 represents elution fractions; 
Eb represents the protein elution by immunoprecipitated boiling protein-A beads with 
sample buffer (Eb). Elution fractions showed that the potential binding partners of PHB, 
which were further processed for In-gel digestion and MALDI-TOF mass spectrometry.  
Coomassie stained gel of immunoprecipitated proteins from oxidative stress (200 μM) 
treated ARPE-19 cells (lysate) with anti-PHB antibody. Cells were harvested, lysed 
followed by Co-IP and separated by SDS-PAGE. Proteins in the W1 to W3 represents 
wash fractions; E1 to E3 represents elution fractions; Eb represents the protein elution by 
immunoprecipitated boiling protein-A beads with sample buffer (Eb). Protein standard 
(marker) represents the size between 10 to 120 kDa. . Elution fractions showed that the 
potential binding partners of PHB, which were further processed for In-gel digestion and 




Figure 4.13 Co-Immunoprecipitation (Co-IP) of PHB interacting proteins. Coomassie 
stained gel of immunoprecipitated proteins from control human retinal progenitor (HRP) 
cells (lysate) with anti-PHB antibody. Cells were harvested, lysed followed by Co-IP and 
separated by SDS-PAGE. Proteins in the W1 to W3 represents wash fractions; E1 to E3 
represents elution fractions; Eb represents the protein elution by immunoprecipitated 
boiling protein-A beads with sample buffer (Eb). Elution fractions showed that the 
potential binding partners of PHB, which were further processed for In-gel digestion and 
MALDI-TOF mass spectrometry. Coomassie stained gel of immunoprecipitated proteins 
from oxidative stress (100 μM) treated human retinal progenitor cells (lysate) with anti-
PHB antibody. Cells were harvested, lysed followed by Co-IP and separated by SDS-
PAGE. Proteins in the W1 to W3 represents wash fractions; E1 to E3 represents elution 
fractions; Eb represents the protein elution by immunoprecipitated boiling protein-A 
beads with sample buffer (Eb). Protein standard (marker) represents the size between 10 
to 120 kDa. Elution fractions showed that the potential binding partners of PHB, which 






 Table 4.1 Potential binding partners of prohibitin from human retinal pigment epithelial (ARPE-19) and human retinal progenitor (HRP) cells.  
Band   Accession               Protein identified                                                      score              %coverage      Mass     PI    Peptide  
A1       83404899  Kinesin Family member 19 protein   47325  8.2 93161     6.2          7                                                                                                                                                                                                    
A1     194388398  Myosin head (motor domain)   253758  9.0 110912     8.5     7 
A13     26330300  Cadherin_repeat (Ca2+ binding site)   633431  10.0 88790     4.7     6 
A16         292352  Collagen, partial     189998  11.0 72107     7.3     5                     
A18     74187742  Nucleoporin-like protein    1.95e+6  12.0 86380     6.5         6                                                                  
A22       2217933  PKU-beta(Serine/Threonine kinases)  2211  7.6 88883     8.9         4                   
A22       8392959  Beta-1,4-galactosyltransferase 2   3975  15.4 41910     9.4    4 
A22   113195686  Lamin-B2     3513  10.9 67319     5.4    4 
A23   194388398  Myosin head (motor domain)   9.80e+7  15.1 110912     8.5  12                     
A25   158259341  PI3-Kinase,p 85 binding domain protein  645600  11.6 124285     6.9    8                  
A28     40352738  Ion transport protein    306309  18.5 61801     5.5    5                      
A32       4220898  Transcriptional co-activator CRSP130  441010  8.4 106209     8.5   6 
A33     41945518  Tiam1 PH domain lipid binding protein  105719  8.6 99654     8.7   7 
A34     38569540  5'-3' exoribonuclease 2 isoform 3   140868  10.6 103802     8.2        7                     
A34   148705232  Leucine rich repeats,pyrin death domain  179814  9.4 112138     8.0   8 
A35         624871  a1(XIX) collagen chain precursor   2.94e+7  12.9 115096     8.4        8                   
 A41     74187742 Nucleoporin-like protein    379387  10.2 86380     6.5    5 
A44     62897409  Beta actin variant     2.47e+8  35.5 41723     5.3      10                
 A45       3603443 Fibrousheathin I     192098  11.7 94617     6.0        5   






A47   119582405  Cadherin_repeat (Ca2+ binding site)  4.44e+8    18.6 88669     5.0  10 
A49     13278786   Nuclear mitotic apparatus protein 1 isoform CRA 1.85e+7  14.2 109280       8.1  11     
                  
Band   Accession               Protein identified                                                      score              %coverage      Mass     PI    Peptide  
H1     194388398  Myosin head (motor domain)   161675  8.6 110912      8.5   7                        
H4     158256650  Meckelin     1.14e+9  14.3 116422     6.2      11           
 H5     119603470 Esterase 31, isoform CRA_e   43420  7.7 59890     5.4        4                       
H6         7019942  5’-3’ Exonuclease    6.28e+6  17.1 63785     9.0    6 
H11     11908000  BCL-6 corepressor short isoform   1.78e+7  17.8 107405     8.8        9                              
 H11   119584312  Inositol 1,4,5-triphosphate receptor, type 1  1.47e+6.  8.8 117553     6.2        6       
 H13   119612108  Transmembrane protein 67, isoform CRA_b  752714  10.2 109958     6.2        6                                                   
H14       5882259  Genethonin 3     9.41e+6  15.3 89342     5.2    8                       
H19     14250401  Actin, beta, partial    4.89e+6  32.3 41005     5.6    9 
H21S   74213524  ACTB protein, partial    1.22e+9  33.6 41751    5.3       10          
H23S     2656123  P-53 binding protein    2881  7.4 93501    9.6    4                       
H26       2102696  Karyopherin beta 3    6.53e+6  13.2 123599    4.8 10 
H29   115529728  Guanine nucleotide exchange factor OSTIII   5.98e+6  8.8 123524    5.7   8 
H32     34189309    Nuclear Pore Protein 107    2.40e+11 19.2 79971    5.2   8 
H34   272982598  Anti-HIV-1 gp120 immunoglobulin heavy chain 4.02e+8  22.4 51810    8.1        8        
 H36       5305448 PH domain containing signaling mediator isoform   175808  16.8 70047    5.7   6 








Band   Accession               Protein identified                                                      score              %coverage      Mass     PI    Peptide  
H39       7661922  Ras related protein Rab-21   38925  33.8 24348    8.1        5       
H41   148692949    Leucine rich repeat containing 21   169639  9.6 111679    6.8        5 
H44   226958677               Guanine nucleotide exchange factor DSB isoform 3 872951  7.6 123694    5.7        8                     
H45   148682292  Retinis pigmentosa 1 homolog (human)  30379  5.1 124037    9.5        6 
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4.4.6 Lipid Binding Pocket in Prohibitin 
Controlled translocalization of prohibitin to specific subcellular organelle under stress 
condition is a critical event for apoptosis, proliferation, lipid metabolism, and aging. We 
speculate that prohibitin translocalization and trafficking might be influenced by specific 
lipid binding sequence and temporal lipid concentration. We hypothesized that prohibitin 
may have a putative lipid binding domains that include conserved basic amino acids. To 
test our hypothesis, we examined whether prohibitin has any homologous lipid binding 
domain or conserved basic amino acids using PFAM database 
(http://www.sanger.ac.uk/software/pfam), Ensembl human genome browser 
(http://www.ensembl.org/homo_sapiens), and support vector machine-based functional 
prediction (http://jing.cz3.nus.edu.sg/cgi-bin/svmprot.cgi).  Lipid binding modules, 
including C1, C2, pleckstrin homology (PH), Phox homology (PX), Fab1-Yop-Vac1-
Eea1 (FVVE), Epsin amino-terminal homology (ENTH), Four-point-one-Ezrin-Radixin-
Moesin (FERM) domains, ANTH, BAR, PDZ, tubby, START, and Src homology 3 
(SH3) domains, were examined.  Previously we demonstrated that prohibitin has a strong 
affinity with phosphatidylinositol 3,4,5-triphosphate (PIP3) and cardiolipin under various 
stress conditions. Prohibitin also has low affinity toward PI (4)P, PI (4,5)P2, 3-
sulfogalactosylceramide, phosphatidic acid and phosphatidylserine. PIP3 interacts with 
PX domain containing proteins that include p40phox, p47phox, phospholipase D1 (PLD1), 
SNX6, and cytokine-independent serine/threonine kinase (CISK or SGK3). Multiple 
sequence alignment demonstrated that two of the most well conserved basic amino acids 
in prohibitin are R35, R43, R72 that are homologous to K75, R90, and R135 of SGK3, 
which represent phosphoinositide binding pocket (Figure 4. 8). R41 and R72 in prohibitin 
are also homologous to R43 and R90 in the PX domain of p47phox (data not shown). 
Other conserved basic residues are K11, K83, R97, R105, R143, R157, K207, and K208 
with SNX6 and SGK3, both known as phosphoinositide binding proteins. We compared 
the PX domain of prohibitin with the known p47phox structure. The conserved basic amino 
acid sequence is homologous to the cationic residues in the putative PIP3 binding pocket 
(R41, R72) of p47phox (data not shown).  Phosphate groups in PIP3 may interact with 
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three arginine residues, R41/43 and R72 of prohibitin. A conserved F42 (F44 in p47phox) 
seems essential for the inositide ring interaction to make U shape PIP3 binding pocket. 
Two conserved proline residues, P64 and P98, suggest a β turn structure, mimicking the 
second anion-binding site of p47phox (P73, P76). Many more conserved basic residues that 
include R143, R157, K207, and K208, imply a putative second anion-binding site (e.g. 
cardiolipin) at C terminus.     
4.5 Discussion 
The current study is aimed to determine whether prohibitin is downregulated in the RPE 
leading to mitochondrial dysfunction in AMD. Decreased prohibitin may modulate lipid 
metabolism, transcriptional activation and RPE apoptosis to accelerate AMD pathway. 
We tested our working hypothesis of inverse correlation of prohibitin expression and 
AMD using in vivo model, prohibitin knockdown and molecular interaction assays. Our 
data demonstrates that prohibitin is depleted in the RPE during AMD pathogenesis. To 
determine the downstream mechanism of prohibitin signaling at the molecular level, we 
examined various prohibitin-binding assays, including mitochondrial/nuclear DNA, 
phospholipid, and immunoprecipitation. As the susceptibility of the RPE and retina to 
oxidative stress is different, altered expression of prohibitin in the RPE and the retina are 
anticipated in the diabetic and aging model. Previously, our data showed that prohibitin is 
differentially expressed in the retina and RPE as an oxidative stress biomarker that 
significantly changed its concentration in light induced stress, aging and diabetic 
conditions (Lee et al., 2011). Further, we demonstrated that 1) stress-dependent 
translocalization of prohibitin between the nucleus and mitochondria as a retrograde 
signal, 2) PIP3 and cardiolipin binding changes under stress, 3) phosphorylation in the 
nucleus and interaction with the tumor suppressor p53, 4) accelerated apoptosis by 
prohibitin depletion. The changes in the expression and localization of prohibitin induced 
by reactive oxygen species are crucial events for mitochondrial integrity. Prohibitin is a 
lipid metabolism switch that binds to PIP3 and cardiolipin in a stress-dependent manner 
(Sripathi et al., 2011c). We speculated that prohibitin may contain lipid binding domain, 
including conserved basic amino acids. The rationale for examining the prohibitin-lipid 
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interaction is that prohibitin showed stress-dependent lipid binding properties in vitro. 
Changes of prohibitin-lipid and protein interaction in RPE cells under oxidative stress 
characterized here will help to identify key elements of apoptotic networks that follow 
lipid metabolism and serve as a framework of biochemical pathways for future studies of 
AMD. Prohibitin-PIP3 interaction leads to attenuation of insulin signaling (Ande and 
Mishra, 2009). PIP3 has a central role in transmitting insulin signaling and may also 
provide a platform for protein-protein interaction. PIP3 acts as a signaling molecule in a 
variety of cellular processes including cell proliferation, cell motility, metabolism, and 
immune response. Prohibitin contains conserved basic amino acid residues as the PX 
domain with 25-50% homology. The PX domain is a phosphoinositide-binding domain 
with many functions including protein sorting, vesicular trafficking and phospholipid 
metabolism. Our multiple sequence alignment shows that prohibitin may have a 
phosphoinisitide binding site that may influence PIP3 and cardiolipin binding. Conserved 
basic residues are R43, R72, K83, R97, and R105 that are aligned with the p47phox, 
SNX6, and SGK3 PX domain. PX domain residues are not highly conserved as shown as 
25-50% compared to other PX domain proteins, however, essential basic amino acids 
with hydrophobic (F, I, L, A) and structural (P, G) amino acids seems enough to make a 
phospholipid binding pocket. A putative secondary pocket also suggests that allosteric or 
post-translational modification-dependent, including T/Y phosphorylation and C 
palmitoylation, regulatory mechanism on lipid binding. We speculate that the origin of 
prohibitin function on metabolism and aging is from altered lipid bindings, including 
cardiolipin and PIP3, under stress condition. Prohibitin binds to PIP3/PI(4,5)P2 with 5 
fold ratio. In normal conditions, PI (4,5)P2 has higher concentration than PIP3, so strong 
PIP3 binding will facilitate PI3K reaction. However, prohibitin modulates this interaction 
toward cardiolipin under oxidative stress, suggesting switch-off function of 
phosphoinositide reaction. Cardiolipin plays an important role in assembly of respiratory 
chain complexes, m-AAA protease complex, and the α-ketoglutarate dehydrogenase 
complex. m-AAA protease removes non-assembled polypeptides from inner 
mitochondrial membrane. Phosphatidylinositol is a key membrane constituent and a 
participant in essential metabolic processes on PI3K pathway. PIP3 stimulates signaling 
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pathways involved in cell growth, survival, motility and proliferation. Phosphoinositide-
binding proteins are phospholipases, protein kinases, membrane trafficking regulators, 
cytoskeletal scaffold, and ion channels. PIP3 binding involves electrostatic interactions 
with the negative charges of the phosphate groups on the inositol ring with characteristic 
clusters of basic amino acid residues in proteins. Prohibitin is a part of mitochondrial 
nucleotide-protein complex to protect endothelial cells against reactive oxygen species-
induced senescence. Fibroblasts lacking prohibitin show aberrant mitochondrial cristae 
and exhibit a decreased resistance toward apoptosis. Apoptotic cells and photoreceptor 
discs are eliminated in circadian dependent manner by the phagocytotic mechanism by 
RPE. PI(4,5)P2 interventions, both degradation and synthesis, compromise phagocytic 
pathway. During phagocytosis, PIP3 and PI3K are regulated for clustering receptors and 
actin polymerization. Considering weak binding of PHB PI (4, 5) P2 and strong binding 
with PIP3, prohibitin may act as a cell fate determinant by altering lipid interaction under 
oxidative stress. Prohibitin has an anti-apoptotic function in mitochondria as the default 
function showing high affinity toward PIP3 under normal condition as a positive 
regulator of PI3K pathway. Prohibitin may become a transcriptional regulator in the 
nucleus under oxidative stress with weaker interaction with PIP3. The dual lipid binding 
switch might be essential to regulate RPE cells from uncontrolled proliferation under 
oxidative and altered lipid environment on diabetes and aging. Depletion of prohibitin 
may affect lipid metabolism in aging- and oxidative stress-dependent manner. Prohibitin-
mediated signaling, including epithelial migration, reversal of obesity, drug sensitivity, 
and longevity, is known (Kolonin et al., 2004a; Rajalingam et al., 2005). Prohibitin was 
proposed as an anti-proliferative protein or a tumor suppressor forming a high molecular 
complex with prohibitin2 in mitochondria. Localization of prohibitin has been 
controversial as being mitochondrial, nuclear, or cell surface possibly due to cell type and 
lipid environment. The current study identified the potential binding partners of 
prohibitin and their putative functional roles in the retina and RPE. Differential 
expression of prohibitin was observed in the postmortem retinas of diabetic retinopathy 
(DR), aged, also in the retinas of mouse and rats in vivo. Region-specific expression of 
prohibitin with respect to retina (macular and peripheral) and RPE (central and 
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peripheral) were observed in the postmortem tissues of AMD. Based on our biochemical 
and proteomic analysis, we suggest that prohibitin is a specific lipid binding modulator in 
diabetes-induced retinopathy and age-related retinal degenerative diseases. Prohibitin 
showed strong affinity with PIP3 compared to PI(4,5)P2. This interaction may facilitate 
the forward reaction of PI3K pathway in normal and stress conditions. Prohibitin 
interacts with cardiolipin as a retrograde response to activate mitochondrial proliferation. 
Lipid binding switch mechanism of prohibitin may suggest the origin of prohibitin effect 



















In this study, we demonstrate that mitochondrial chaperone and anti-apoptotic protein 
prohibitin is translocalized from mitochondria to nucleus in response to oxidative stress. 
Mitochondrial-nuclear (MT-NU) communication by prohibitin shuttling involves lipid 
interaction changes such as PHB-phosphatidylinositol phosphates (PIP3) in normal 
condition compared to PHB- cardiolipin binding and nuclear prohibitin phosphorylation 
during oxidative stress.  Prohibitin interaction with p53 reveals the role of nuclear PHB 
in transcriptional regulation. Our knockdown approach using prohibitin specific small 
interfering RNA (siRNA) resulted in the upregulation of pro-apoptotic proteins (AIF, 
caspases-9, BAK) and downregulation of anti-apoptotic protein (Bcl-xL). The 
phenotypic sub cellular organelle changes provide valid evidence that prohibitin is 
involved in the anti-apoptotic signaling to protect the RPE from oxidative damage. 
Our data reveals that, concentration of NO generation is elevated during intense light 
exposure, oxidative damage and re-oxygenation towards RPE cells. We provide the 
evidence that inducible nitric oxide synthase (iNOS) is actively involved in the 
production of NO and also increase in protein nitration by the formation of 3-
nitrotyrosine in the RPE under oxidative stress. We also determined that upregulation of 
PP2Ac (catalytic subunit) phosphorylation negatively correlates with the vimentin 
phosphorylation under oxidative stress. NO production in the cells enables the down 
regulation of PP2Ac phosphorylation to further achieve vimentin filament stabilization 
during stress induction. The timely generated NO may indirectly influence the 
cytoskeletal dynamics and apoptotic pathways via phosphorylation or 
dephosphorylation signaling. 
 Further, we have identified the potential binding partners of prohibitin in the retina and 
RPE cells under oxidative stress. Increased levels of prohibitin in the central (macular) 
and peripheral retina, and decreased levels of prohibitin in the central (macular) and 
peripheral RPE were identified from age-related macular degeneration (AMD) donor 
eyes. We also found that prohibitin in the retinas of diabetic retinopathy is increased 
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from rats, mouse and humans. On the other hand, increase in expression of prohibitin 



















 FUTURE DIRECTIONS 
We found that prohibitin is up regulated in the retina but down regulated in the RPE of 
age-related macular degeneration (AMD) and diabetic retinopathy (DR). The tissue 
specific prohibitin expression and regulation is needed to be clearly understood in 
transgenic animal models. Retinal neo-vascularization is the common pathological 
feature in diabetic retinopathy (DR), AMD and retinopathy of prematurity (ROP), so 
understanding the role of prohibitin during hypoxia induced retinal angiogenesis may 
reveal its crucial function in retinal degenerative diseases.  Identification of prohibitin 
interacting protein network will unveil the various signaling pathways that are involved 
in prohibitin expression and regulation in disease condition. Sequence-specific DNA-
prohibitin binding is crucial in understanding the nuclear functions of prohibitin in the 
retina and RPE. We observed that nuclear prohibitin is phosphorylated, however, other 
post translational modifications such as acetylation, palmitoylation, and glycosylation 
need to be confirmed. We measured the concentration of nitric oxide generated from 
RPE cells in vitro, however, the ideal levels of NO required for RPE protection from 
apoptosis need to be established. As the RPE cells release NO under stress response, 
determining the beneficial or deleterious effects of such NO on neural retina is highly 
necessary. NO signaling studies need to be performed in age-related macular 
degeneration, diabetic retinopathy and aged models in vivo. In our study, we mainly 
focused on biochemical and proteomic approaches to understand the involvement of 
various proteins during retina and RPE apoptosis. Identification of complete protein, 
lipid binding network, and detailed phosphorylation signaling for target proteins is 
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